<!DOCTYPE html>
<html>
<head>
  <meta charset="UTF-8">
  <style>
    #vis.vega-embed {
      width: 100%;
      display: flex;
    }

    #vis.vega-embed details,
    #vis.vega-embed details summary {
      position: relative;
    }
  </style>
  <script type="text/javascript" src="https://cdn.jsdelivr.net/npm/vega@5"></script>
  <script type="text/javascript" src="https://cdn.jsdelivr.net/npm/vega-lite@5.20.1"></script>
  <script type="text/javascript" src="https://cdn.jsdelivr.net/npm/vega-embed@6"></script>
</head>
<body>
  <div id="vis"></div>
  <script>
    (function(vegaEmbed) {
      var spec = {"config": {"view": {"continuousWidth": 300, "continuousHeight": 300, "stroke": null}}, "vconcat": [{"data": {"name": "data-d68d82c4244cbe0891bbd8734ed595b9"}, "mark": {"type": "bar"}, "encoding": {"tooltip": [{"field": "GPT_Name", "type": "nominal"}, {"field": "Topic", "type": "quantitative"}, {"field": "Best Fit Slope", "type": "quantitative"}], "x": {"field": "GPT_Name", "sort": "-y", "type": "nominal"}, "y": {"field": "Best Fit Slope", "type": "quantitative"}}}, {"layer": [{"data": {"name": "data-b862d70ba9859ace83af955ded11dbb9"}, "mark": {"type": "line"}, "encoding": {"color": {"field": "variable", "legend": {"columns": 1, "symbolLimit": 0}, "scale": {"domain": ["FLASH Proton RT Normal Tissue Radioprotection", "Proton Therapy for Head and Neck Cancer Survival", "Radiation Immunotherapy for Tumor Control and Survival", "IMRT for Head Neck Cancer Toxicity and Survival", "Adaptive IMRT for Cervical Cancer Toxicity", "Radiation Therapy Outcomes for Lymphoma Patients"], "range": ["#2C267A", "#5291FF", "#4DE8DE", "#EF1700", "#DB0F07", "#AB1C37"]}, "type": "nominal"}, "x": {"field": "Year", "type": "nominal"}, "y": {"field": "value", "type": "quantitative"}}}, {"data": {"name": "data-8c9c571495a43745bc353fbe0c94d115"}, "mark": {"type": "circle"}, "encoding": {"color": {"field": "variable", "legend": {"columns": 1, "symbolLimit": 0}, "scale": {"domain": ["FLASH Proton RT Normal Tissue Radioprotection", "Proton Therapy for Head and Neck Cancer Survival", "Radiation Immunotherapy for Tumor Control and Survival", "IMRT for Head Neck Cancer Toxicity and Survival", "Adaptive IMRT for Cervical Cancer Toxicity", "Radiation Therapy Outcomes for Lymphoma Patients"], "range": ["#2C267A", "#5291FF", "#4DE8DE", "#EF1700", "#DB0F07", "#AB1C37"]}, "type": "nominal"}, "x": {"field": "Year", "type": "nominal"}, "y": {"field": "value", "type": "quantitative"}}}], "width": 600}], "resolve": {"legend": {"color": "independent"}}, "$schema": "https://vega.github.io/schema/vega-lite/v5.20.1.json", "datasets": {"data-d68d82c4244cbe0891bbd8734ed595b9": [{"topic_id": -1, "Total Count": 295, "2023": 34, "2024": 5, "2022": 21, "2021": 34, "2020": 24, "2019": 17, "2018": 25, "2017": 22, "2016": 19, "2015": 23, "2014": 32, "2013": 39, "Topic": 0, "GPT_Name": "Outlier Cluster", "original_word_representation": null, "Best Fit Slope": -1.0384615384615385, "Intercepts": 2120.717948717949}, {"topic_id": 0, "Total Count": 360, "2023": 36, "2024": 8, "2022": 21, "2021": 36, "2020": 31, "2019": 25, "2018": 34, "2017": 37, "2016": 37, "2015": 30, "2014": 28, "2013": 37, "Topic": 1, "GPT_Name": "IMRT for Head Neck Cancer Toxicity and Survival", "original_word_representation": "patients, neck, hpv, head neck, rt, dose, head, treatment, survival, therapy, radiation, imrt, cancer, crt, radiation therapy, grade, carcinoma, gy, os, risk, toxicity, model, ci, squamous, esophageal, xerostomia, squamous cell, group, tumor, quality, year, clinical, months, neck cancer, study, patient, volume, analysis, cell, disease, overall, stage, arm, free, oropharyngeal, median, cell carcinoma, plans, associated, vs", "Best Fit Slope": -1.1958041958041958, "Intercepts": 2443.7307692307695}, {"topic_id": 1, "Total Count": 132, "2023": 11, "2024": 3, "2022": 8, "2021": 8, "2020": 7, "2019": 13, "2018": 11, "2017": 14, "2016": 15, "2015": 11, "2014": 8, "2013": 23, "Topic": 2, "GPT_Name": "Ultrahypofractionated WPRT for Prostate Cancer Toxicity", "original_word_representation": "prostate, prostate cancer, ebrt, psa, adt, patients, risk, men, cancer, rt, biochemical, high risk, therapy, high, ci, gleason, hr, risk prostate, specific, ml, radiation, radiation therapy, survival, androgen, pca, deprivation, score, androgen deprivation, treatment, disease, months, rp, intermediate, prostatectomy, prostate specific, specific antigen, deprivation therapy, antigen, median, treated, gleason score, dose, localized, ng, ng ml, bt, analysis, mortality, year, metastasis", "Best Fit Slope": -0.9370629370629371, "Intercepts": 1902.4615384615386}, {"topic_id": 2, "Total Count": 118, "2023": 6, "2024": 2, "2022": 5, "2021": 7, "2020": 4, "2019": 8, "2018": 11, "2017": 9, "2016": 11, "2015": 27, "2014": 15, "2013": 13, "Topic": 3, "GPT_Name": "Radiation Therapy Outcomes for Lymphoma Patients", "original_word_representation": "lymphoma, rt, patients, hl, disease, stage, chemotherapy, therapy, radiation, hodgkin, response, relapse, os, hodgkin lymphoma, dose, treatment, radiation therapy, survival, relapsed, cell lymphoma, involved, pet, pfs, risk, median, sites, field, year, early, progression, mediastinal, early stage, refractory, gy, years, ii, cr, treated, cell, received, complete, salvage, follow, primary, associated, stage ii, ct, large, overall, months", "Best Fit Slope": -1.3776223776223777, "Intercepts": 2790.564102564103}, {"topic_id": 3, "Total Count": 95, "2023": 6, "2024": 3, "2022": 10, "2021": 10, "2020": 9, "2019": 6, "2018": 5, "2017": 8, "2016": 10, "2015": 6, "2014": 10, "2013": 12, "Topic": 4, "GPT_Name": "Breast Cancer: Toxicity, Local Control, Survival", "original_word_representation": "breast, cosmesis, patients, cosmetic, breast irradiation, breast cancer, toxicity, boost, years, irradiation, grade, skin, excellent, partial breast, rt, follow, breast conserving, gy, conserving, cancer, fractions, good, reported, recurrence, accelerated, treatment, partial, local, conserving surgery, women, surgery, trial, year, radiation, daily, invasive, dose, accelerated partial, outcomes, treated, hypofractionated, late, therapy, rate, ci, patient, lumpectomy, median, pain, acute", "Best Fit Slope": -0.36013986013986016, "Intercepts": 734.8589743589744}, {"topic_id": 4, "Total Count": 87, "2023": 3, "2024": 2, "2022": 27, "2021": 12, "2020": 4, "2019": 7, "2018": 8, "2017": 2, "2016": 11, "2015": 6, "2014": 3, "2013": 2, "Topic": 5, "GPT_Name": "Proton Therapy for Head and Neck Cancer Survival", "original_word_representation": "patients, sabr, oligometastatic, disease, survival, therapy, sbrt, cost, os, months, pfs, progression, local, metastases, oligometastatic disease, imrt, metastatic, lesions, treatment, median, systemic, toxicity, control, gy, free, radiation, proton, systemic therapy, grade, dose, free survival, rt, overall, radiation therapy, respectively, ci, failure, primary, progression free, overall survival, treated, lung, effective, cancer, follow, model, year, time, stereotactic, lc", "Best Fit Slope": 0.548951048951049, "Intercepts": -1100.8076923076924}, {"topic_id": 5, "Total Count": 99, "2023": 8, "2024": 0, "2022": 2, "2021": 11, "2020": 9, "2019": 7, "2018": 7, "2017": 8, "2016": 21, "2015": 8, "2014": 10, "2013": 8, "Topic": 6, "GPT_Name": "Proton Therapy Optimization for Lung Cancer Toxicity and Survival", "original_word_representation": "proton, dose, rbe, proton therapy, plans, beam, target, biological, optimization, energy, plan, treatment, planning, range, therapy, using, robustness, clinical, uncertainties, ion, mm, tissue, protons, robust, carbon, motion, monte, carlo, monte carlo, distributions, scanning, biological effectiveness, patients, ct, delivery, normal, coverage, patient, photon, treatment planning, lung, setup, field, physical, beams, based, effectiveness, peak, measurements, phantom", "Best Fit Slope": -0.6818181818181818, "Intercepts": 1384.5}, {"topic_id": 6, "Total Count": 82, "2023": 8, "2024": 3, "2022": 4, "2021": 8, "2020": 5, "2019": 6, "2018": 12, "2017": 7, "2016": 7, "2015": 5, "2014": 9, "2013": 8, "Topic": 7, "GPT_Name": "SBRT and Proton Therapy for Liver HCC Outcomes", "original_word_representation": "liver, sbrt, hcc, patients, hepatocellular, hepatocellular carcinoma, dose, rt, months, hepatic, local, response, score, carcinoma hcc, gy, carcinoma, os, toxicity, survival, treated, radiation, stereotactic body, tumor, median, therapy, function, body, body radiation, stereotactic, treatment, local control, control, therapy sbrt, metastases, ci, radiation therapy, tumors, disease, progression, grade, baseline, perfusion, respectively, overall, group, proton, year, using, sabr, model", "Best Fit Slope": -0.2727272727272727, "Intercepts": 557.3333333333334}, {"topic_id": 7, "Total Count": 88, "2023": 6, "2024": 3, "2022": 3, "2021": 2, "2020": 6, "2019": 7, "2018": 9, "2017": 9, "2016": 7, "2015": 7, "2014": 12, "2013": 17, "Topic": 8, "GPT_Name": "Anal Cancer Proton Therapy Toxicity", "original_word_representation": "patients, rectal, rectal cancer, crt, cancer, chemoradiation, preoperative, survival, anal, imrt, response, pcr, mg, chemotherapy, therapy, complete, surgery, rate, treatment, toxicity, grade, radiation, tumor, arm, local, disease, complete response, rates, group, locally, vs, year, free, radiation therapy, recurrence, pathologic, neoadjuvant, free survival, treated, respectively, advanced, locally advanced, chemoradiation therapy, resection, stage, boost, concurrent, months, os, gy", "Best Fit Slope": -0.951048951048951, "Intercepts": 1927.0256410256409}, {"topic_id": 8, "Total Count": 81, "2023": 2, "2024": 3, "2022": 5, "2021": 5, "2020": 6, "2019": 5, "2018": 5, "2017": 12, "2016": 7, "2015": 7, "2014": 9, "2013": 15, "Topic": 9, "GPT_Name": "SRS Dose and Fractionation for Brain Metastases Outcomes", "original_word_representation": "srs, brain, wbrt, metastases, brain metastases, patients, radiosurgery, stereotactic radiosurgery, radiosurgery srs, lesions, stereotactic, ci, local, months, median, bm, resection, treated, mri, survival, control, risk, local control, gy, dose, os, treatment, hr, brain radiation, patients brain, volume, tumor, single, analysis, failure, surgical, intracranial, associated, rates, factors, cm, month, postoperative, respectively, target, radiation, cavity, year, necrosis, overall", "Best Fit Slope": -0.8286713286713286, "Intercepts": 1679.423076923077}, {"topic_id": 9, "Total Count": 75, "2023": 6, "2024": 1, "2022": 4, "2021": 4, "2020": 6, "2019": 5, "2018": 6, "2017": 8, "2016": 4, "2015": 6, "2014": 10, "2013": 15, "Topic": 10, "GPT_Name": "Prostate IMRT Late Toxicity and Quality of Life", "original_word_representation": "prostate, rectal, toxicity, bladder, dose, late, rt, patients, gy, prostate cancer, radiation, grade, acute, bleeding, symptoms, therapy, imrt, radiation therapy, gu, urinary, volume, cancer, risk, gi, treatment, dose volume, induced, gu toxicity, bowel, incontinence, model, radiation induced, study, using, ntcp, rectum, associated, significant, effects, analysis, therapy prostate, sbrt, group, frequency, treated, significantly, dysfunction, crt, increased, auc", "Best Fit Slope": -0.7377622377622378, "Intercepts": 1495.4230769230771}, {"topic_id": 10, "Total Count": 76, "2023": 2, "2024": 2, "2022": 3, "2021": 2, "2020": 4, "2019": 6, "2018": 10, "2017": 4, "2016": 6, "2015": 9, "2014": 15, "2013": 13, "Topic": 11, "GPT_Name": "FDG-PET Response in Adaptive Lung Radiation", "original_word_representation": "pet, fdg, ct, fdg pet, dose, tumor, patients, pet ct, tomography, volume, lung, plans, therapy, planning, positron, positron emission, emission tomography, imaging, radiation, uptake, emission, nsclc, computed, scans, gtv, computed tomography, radiation therapy, treatment, using, mm, cancer, crt, tumors, target, motion, primary, imrt, metabolic, response, based, beams, scan, lung cancer, mean, model, gy, fluorodeoxyglucose, plan, rt, target volume", "Best Fit Slope": -1.0629370629370631, "Intercepts": 2151.8717948717954}, {"topic_id": 11, "Total Count": 59, "2023": 6, "2024": 2, "2022": 4, "2021": 7, "2020": 1, "2019": 3, "2018": 6, "2017": 3, "2016": 6, "2015": 4, "2014": 7, "2013": 10, "Topic": 12, "GPT_Name": "SBRT for Locally Advanced Pancreatic Cancer Toxicity and Survival", "original_word_representation": "pancreatic, pancreatic cancer, patients, sbrt, dose, survival, os, crt, months, ci, resection, therapy, toxicity, chemoradiation, chemotherapy, cancer, median, adenocarcinoma, gy, radiation, tumor, locally advanced, mg, advanced, unresectable, grade, locally, hr, treatment, fractions, adjuvant, radiation therapy, local, neoadjuvant, progression, ptv, received, volume, overall, distant, dose escalation, using, overall survival, ct, escalation, patients received, pain, trial, respectively, induction", "Best Fit Slope": -0.3531468531468531, "Intercepts": 717.7435897435896}, {"topic_id": 12, "Total Count": 57, "2023": 10, "2024": 1, "2022": 3, "2021": 9, "2020": 6, "2019": 11, "2018": 5, "2017": 3, "2016": 3, "2015": 1, "2014": 2, "2013": 3, "Topic": 13, "GPT_Name": "Prostate SBRT: Toxicity and Quality of Life", "original_word_representation": "prostate, sbrt, toxicity, prostate cancer, qol, patients, gy, urinary, gu, dose, grade, biochemical, months, cancer, gi, therapy, genitourinary, scores, late, quality life, gastrointestinal, acute, radiation therapy, reported, boost, radiation, fractions, toxicities, sexual, risk, ebrt, life, intermediate, intermediate risk, quality, patient, median, bowel, ci, gy fractions, events, treatment, baseline, follow, adverse, stereotactic, index, gu toxicity, stereotactic body, respectively", "Best Fit Slope": 0.3811188811188811, "Intercepts": -764.5384615384614}, {"topic_id": 13, "Total Count": 58, "2023": 2, "2024": 1, "2022": 9, "2021": 9, "2020": 2, "2019": 7, "2018": 1, "2017": 7, "2016": 5, "2015": 4, "2014": 5, "2013": 6, "Topic": 14, "GPT_Name": "Proton Therapy for Breast Cancer Cardiac Toxicity", "original_word_representation": "cardiac, heart, left, rt, breast, sided, dose, breast cancer, left sided, patients, risk, heart dose, gy, radiation, mean, cancer, ct, artery, therapy, radiation therapy, motion, women, volume, treatment, perfusion, doses, planning, dimensional, proton, right, imrt, median, increased, associated, computed tomography, computed, range, tomography, anterior, target, plans, events, ci, scans, function, dose volume, disease, trial, study, changes", "Best Fit Slope": -0.1258741258741259, "Intercepts": 258.9102564102564}, {"topic_id": 14, "Total Count": 68, "2023": 7, "2024": 2, "2022": 1, "2021": 7, "2020": 3, "2019": 3, "2018": 7, "2017": 9, "2016": 8, "2015": 7, "2014": 9, "2013": 5, "Topic": 15, "GPT_Name": "SBRT for Lung NSCLC: Local Control and Survival", "original_word_representation": "sbrt, patients, lung, nsclc, lung cancer, stage, gy, os, survival, fractions, cell lung, small cell, local, non small, dose, stereotactic, median, non, body radiation, stereotactic body, small, body, early stage, control, cell, tumor, grade, early, inoperable, tumors, failure, year, months, radiation, therapy sbrt, local control, stage non, respectively, toxicity, cancer, radiation therapy, therapy, lr, overall survival, arm, overall, sabr, outcomes, peripheral, treated", "Best Fit Slope": -0.4195804195804196, "Intercepts": 852.5897435897435}, {"topic_id": 15, "Total Count": 51, "2023": 5, "2024": 0, "2022": 3, "2021": 7, "2020": 1, "2019": 4, "2018": 8, "2017": 3, "2016": 3, "2015": 3, "2014": 8, "2013": 6, "Topic": 16, "GPT_Name": "Pediatric Brainstem Toxicity After Proton Therapy", "original_word_representation": "proton, pediatric, patients, children, therapy, radiation, brain, treated, dose, proton therapy, rt, age, cognitive, photon, years, median, pediatric patients, tumors, radiation therapy, gy, risk, range, proton radiation, treated proton, irradiation, central nervous, nervous, chemotherapy, mean, injury, brain tumors, baseline, posterior, patients treated, treatment, survival, tumor, cranial, ci, central, toxicity, significant, clinical, associated, follow, rbe, data, white, incidence, scores", "Best Fit Slope": -0.2902097902097902, "Intercepts": 590.0384615384615}, {"topic_id": 16, "Total Count": 62, "2023": 1, "2024": 2, "2022": 0, "2021": 1, "2020": 3, "2019": 0, "2018": 6, "2017": 4, "2016": 7, "2015": 7, "2014": 9, "2013": 22, "Topic": 17, "GPT_Name": "Adaptive IMRT for Cervical Cancer Toxicity", "original_word_representation": "prostate, motion, mm, dose, plans, target, ptv, ctv, vmat, bladder, imrt, real time, tracking, margins, real, coverage, volume, margin, time, patients, plan, planning, treatment, beam, planned, fractions, image, modulated, therapy, gy, target volume, prostate cancer, delivered, rectum, ct, adaptive, position, using, mean, cbct, guided, direction, radiation therapy, average, daily, delivery, dosimetric, radiation, cancer, directions", "Best Fit Slope": -1.3286713286713288, "Intercepts": 2687.0897435897436}, {"topic_id": 17, "Total Count": 50, "2023": 10, "2024": 5, "2022": 7, "2021": 8, "2020": 4, "2019": 3, "2018": 1, "2017": 1, "2016": 5, "2015": 1, "2014": 2, "2013": 3, "Topic": 18, "GPT_Name": "FLASH Proton RT Normal Tissue Radioprotection", "original_word_representation": "dose rate, dose, proton, oxygen, irradiation, gy, rate, dna, cells, beam, beams, conventional, effect, damage, repair, radiation, cell, protons, rates, energy, irradiated, sparing, tumor, rays, using, linear, ion, normal, biological, tissue, delivery, high, peak, doses, rbe, high dose, induced, therapy, clinical, energy transfer, linear energy, electron, compared, dna damage, relative, transfer, response, model, normal tissue, human", "Best Fit Slope": 0.5664335664335663, "Intercepts": -1139.1794871794868}, {"topic_id": 18, "Total Count": 56, "2023": 0, "2024": 0, "2022": 7, "2021": 1, "2020": 4, "2019": 8, "2018": 12, "2017": 2, "2016": 10, "2015": 6, "2014": 3, "2013": 3, "Topic": 19, "GPT_Name": "MR-guided Adaptive Radiation Therapy Toxicity and Control", "original_word_representation": "mr, mri, ct, images, magnetic, based, planning, magnetic resonance, resonance, mean, imaging, using, dose, plans, error, adaptive, image, guided, weighted, method, ptv, t1, algorithm, oar, treatment, segmentation, computed, generated, patients, prostate, online, plan, resonance imaging, computed tomography, radiation, tomography, patient, volume, therapy, accuracy, imaging mri, radiation therapy, dice, clinical, density, treatment planning, mm, similarity, bone, t2", "Best Fit Slope": -0.3356643356643357, "Intercepts": 682.2051282051282}, {"topic_id": 19, "Total Count": 53, "2023": 2, "2024": 0, "2022": 1, "2021": 8, "2020": 5, "2019": 6, "2018": 7, "2017": 3, "2016": 9, "2015": 4, "2014": 3, "2013": 5, "Topic": 20, "GPT_Name": "Radiation Dose and Immune Outcomes in NSCLC", "original_word_representation": "tumor, hypoxia, tumors, rt, immune, radiation, oxygen, therapy, vascular, cells, immunotherapy, radiation therapy, growth, combination, cell, response, dose, increased, treatment, day, tumor growth, lymphocyte, imaging, patients, gy, control, changes, potential, effects, doses, irradiation, combined, using, induced, preclinical, clinical, high, mice, expression, xenograft, perfusion, significant, tumor control, microenvironment, associated, cervical, single, blood, levels, local", "Best Fit Slope": -0.2972027972027972, "Intercepts": 604.3205128205127}, {"topic_id": 20, "Total Count": 68, "2023": 3, "2024": 1, "2022": 5, "2021": 4, "2020": 7, "2019": 8, "2018": 5, "2017": 2, "2016": 5, "2015": 7, "2014": 8, "2013": 13, "Topic": 21, "GPT_Name": "Supraclavicular Radiation Dose and Breast Cancer Survival", "original_word_representation": "breast, breast cancer, patients, recurrence, positive, mastectomy, risk, cancer, survival, hr, locoregional, year, ci, women, vs, rt, lr, nodes, os, years, analysis, disease, therapy, breast conserving, conserving, postmastectomy, hr ci, surgery, treated, margins, stage, group, negative, dfs, associated, radiation, rates, cohort, hazard, locoregional recurrence, regional, free, node, nodal, respectively, adjuvant, follow, outcomes, local, subtype", "Best Fit Slope": -0.6223776223776224, "Intercepts": 1261.9358974358975}, {"topic_id": 21, "Total Count": 51, "2023": 8, "2024": 1, "2022": 4, "2021": 4, "2020": 2, "2019": 3, "2018": 5, "2017": 4, "2016": 3, "2015": 5, "2014": 6, "2013": 6, "Topic": 22, "GPT_Name": "Adaptive Radiation Therapy for Cervical Cancer Toxicity**", "original_word_representation": "registration, mm, ct, contours, using, pet, dose, planning, model, segmentation, accuracy, patient, images, target, patients, manual, mean, image, imaging, similarity, clinical, distance, ctv, deep, mr, volume, dice, treatment, tomography, based, computed, coefficient, radiation, average, learning, dice similarity, treatment planning, mri, similarity coefficient, gtv, computed tomography, phantom, method, plans, pet ct, contouring, head, therapy, setup, tumor", "Best Fit Slope": -0.16433566433566432, "Intercepts": 335.96153846153845}, {"topic_id": 22, "Total Count": 48, "2023": 5, "2024": 3, "2022": 7, "2021": 2, "2020": 5, "2019": 3, "2018": 3, "2017": 1, "2016": 4, "2015": 3, "2014": 4, "2013": 8, "Topic": 23, "GPT_Name": "Lung SBRT Toxicity and Local Control", "original_word_representation": "lung, pneumonitis, dose, patients, sbrt, rp, volume, grade, toxicity, radiation, pulmonary, gy, lung cancer, risk, lung dose, nsclc, dosimetric, cell lung, small cell, non small, small, analysis, therapy, non, v20, radiation therapy, factors, radiation pneumonitis, cell, function, mean lung, rt, tumor, ci, capacity, months, treated, body, cancer, stereotactic, stereotactic body, associated, high, thoracic, receiving, parameters, body radiation, doses, mean, model", "Best Fit Slope": -0.055944055944055944, "Intercepts": 116.92307692307692}, {"topic_id": 23, "Total Count": 48, "2023": 1, "2024": 0, "2022": 1, "2021": 1, "2020": 1, "2019": 2, "2018": 5, "2017": 10, "2016": 7, "2015": 4, "2014": 7, "2013": 9, "Topic": 24, "GPT_Name": "Salvage HDR Brachytherapy for Recurrent Prostate Cancer", "original_word_representation": "prostate, brachytherapy, hdr, patients, biochemical, prostate cancer, risk, psa, intermediate, toxicity, low, rate, failure, dose, intermediate risk, grade, bt, median, dose rate, late, treatment, salvage, risk prostate, gy, ml, monotherapy, cancer, recurrence, follow, high, treated, rates, prostate specific, specific antigen, antigen, low intermediate, survival, biochemical failure, late grade, genitourinary, specific, fractions, ebrt, disease, control, high dose, fraction, year, range, patients treated", "Best Fit Slope": -0.8181818181818182, "Intercepts": 1655.5}, {"topic_id": 24, "Total Count": 41, "2023": 2, "2024": 1, "2022": 0, "2021": 5, "2020": 1, "2019": 4, "2018": 3, "2017": 5, "2016": 5, "2015": 1, "2014": 9, "2013": 5, "Topic": 25, "GPT_Name": "Definitive Radiation Therapy for Muscle-Invasive Bladder Cancer Outcomes", "original_word_representation": "bladder, bladder cancer, patients, invasive, muscle, chemotherapy, therapy, radical, radiation, ci, survival, cancer, radiation therapy, treatment, toxicity, preservation, os, pelvic, disease, year, nodes, complete, risk, response, rt, months, dose, rates, clinical, crt, hr, stage, complete response, treated, chemoradiation, dfs, adjuvant, concurrent, tumor, rate, study, mg, group, analysis, grade, free, median, adjuvant radiation, overall, specific survival", "Best Fit Slope": -0.43706293706293703, "Intercepts": 885.628205128205}, {"topic_id": 25, "Total Count": 55, "2023": 8, "2024": 2, "2022": 2, "2021": 2, "2020": 6, "2019": 1, "2018": 9, "2017": 1, "2016": 3, "2015": 10, "2014": 6, "2013": 5, "Topic": 26, "GPT_Name": "Hypofractionated Radiation for Locally Advanced NSCLC Survival", "original_word_representation": "nsclc, patients, os, survival, crt, lung cancer, cell lung, ci, small cell, lung, months, stage, non small, pfs, gy, small, non, imrt, therapy, median, radiation, cell, concurrent, dose, grade, chemoradiation, cancer nsclc, cancer, stage iii, iii, rt, overall, hr, progression, outcomes, concurrent chemoradiation, chemotherapy, toxicity, radiation therapy, overall survival, free, group, treated, associated, nsclc patients, chemoradiation therapy, free survival, advanced, hr ci, daily", "Best Fit Slope": -0.24125874125874125, "Intercepts": 491.56410256410254}, {"topic_id": 26, "Total Count": 42, "2023": 8, "2024": 4, "2022": 5, "2021": 3, "2020": 2, "2019": 4, "2018": 4, "2017": 2, "2016": 4, "2015": 0, "2014": 3, "2013": 3, "Topic": 27, "GPT_Name": "High-Dose IMRT for Prostate Cancer Toxicity", "original_word_representation": "prostate, toxicity, gi, gu, gy, grade, prostate cancer, patients, late, gi toxicity, acute, arm, gu toxicity, hypofractionated, fractions, ci, imrt, urinary, cancer, therapy, year, rt, gastrointestinal, radiation therapy, cohort, genitourinary, radiation, biochemical, risk, randomized, late grade, bowel, reported, localized prostate, months, pelvic, follow, score, dose, free, hypofractionation, gastrointestinal gi, group, localized, high risk, phase, pelvic lymph, men, incontinence, quality life", "Best Fit Slope": 0.3006993006993007, "Intercepts": -603.4615384615385}, {"topic_id": 27, "Total Count": 39, "2023": 1, "2024": 2, "2022": 1, "2021": 4, "2020": 2, "2019": 1, "2018": 5, "2017": 3, "2016": 4, "2015": 0, "2014": 9, "2013": 7, "Topic": 28, "GPT_Name": "IMRT for High-Risk Meningioma Progression-Free Survival", "original_word_representation": "srs, patients, radiosurgery, tumor, ci, gy, dose, follow, months, stereotactic, median, treatment, stereotactic radiosurgery, tumors, grade, pain, years, radiation, control, pfs, vs, term, year, treated, local, respectively, long term, expansion, risk, resection, actuarial, group, long, fraction, single, single fraction, radiosurgery srs, rt, prior, hr, visual, volume, rates, time, intracranial, progression, cm, patients treated, experienced, fractionated", "Best Fit Slope": -0.44405594405594406, "Intercepts": 899.5769230769231}, {"topic_id": 28, "Total Count": 39, "2023": 1, "2024": 0, "2022": 3, "2021": 3, "2020": 3, "2019": 3, "2018": 4, "2017": 4, "2016": 4, "2015": 9, "2014": 2, "2013": 3, "Topic": 29, "GPT_Name": "Spine Metastases SBRT Local Control and Toxicity", "original_word_representation": "spinal, spine, sbrt, pain, cord, gy, patients, spinal cord, months, metastases, fractions, single, dose, srs, radiation, stereotactic, local, volume, control, median, body, ci, range, gy fractions, fraction, treated, respectively, stereotactic body, radiation therapy, hr, body radiation, therapy, rates, postoperative, single fraction, rt, cases, survival, treatment, tumor, local control, irradiated, follow, score, cm, analysis, lc, therapy sbrt, gtv, risk", "Best Fit Slope": -0.32517482517482516, "Intercepts": 659.6153846153845}, {"topic_id": 29, "Total Count": 53, "2023": 1, "2024": 3, "2022": 0, "2021": 2, "2020": 1, "2019": 3, "2018": 5, "2017": 2, "2016": 11, "2015": 4, "2014": 6, "2013": 15, "Topic": 30, "GPT_Name": "Brain SRS: CBCT Image Guidance Accuracy", "original_word_representation": "motion, cbct, mm, breathing, respiratory, position, images, ct, image, tumor, lung, treatment, dimensional, beam, target, using, tracking, average, accuracy, registration, based, patients, marker, cone beam, cone, time, sbrt, mean, computed, dose, volume, liver, tomography, planning, errors, error, acquired, imaging, scans, computed tomography, phase, patient, direction, real time, internal, delivery, mm mm, spine, shift, displacement", "Best Fit Slope": -0.8916083916083916, "Intercepts": 1804.128205128205}, {"topic_id": 30, "Total Count": 41, "2023": 3, "2024": 3, "2022": 3, "2021": 2, "2020": 0, "2019": 1, "2018": 7, "2017": 6, "2016": 2, "2015": 7, "2014": 5, "2013": 2, "Topic": 31, "GPT_Name": "Functional Lung Avoidance Radiation Toxicity", "original_word_representation": "lung, functional, ct, avoidance, perfusion, imaging, function, dose, metrics, pet, patients, rt, based, tomography, pneumonitis, images, computed, lung cancer, computed tomography, volume, using, radiation, planning, image, scans, gy, regional, spatial, plans, regions, changes, parameters, cancer, therapy, mean, grade, pet ct, registration, guided, radiation therapy, patient, dimensional, used, pulmonary, ct scans, rp, dimensional computed, data, anatomic, trial", "Best Fit Slope": -0.2062937062937063, "Intercepts": 419.8205128205129}, {"topic_id": 31, "Total Count": 40, "2023": 1, "2024": 0, "2022": 2, "2021": 6, "2020": 6, "2019": 4, "2018": 3, "2017": 2, "2016": 6, "2015": 4, "2014": 4, "2013": 2, "Topic": 32, "GPT_Name": "Radiation Oncology Resident Training Outcomes", "original_word_representation": "residents, radiation oncology, residency, oncology, program, programs, ro, survey, resident, respondents, academic, radiation, training, medical, positions, number, reported, education, publications, vs, index, rank, matching, data, choice, year, experiences, response rate, pd, practice, research, factors, total, participating, significant, distributed, scores, rate, did, position, range, percentage, size, oncologists, percent, response, concerns, interquartile range, location, interquartile", "Best Fit Slope": -0.17482517482517484, "Intercepts": 356.21794871794873}, {"topic_id": 32, "Total Count": 38, "2023": 14, "2024": 0, "2022": 1, "2021": 2, "2020": 1, "2019": 3, "2018": 1, "2017": 3, "2016": 5, "2015": 2, "2014": 0, "2013": 6, "Topic": 33, "GPT_Name": "Pediatric Radiation Therapy Renal Toxicity", "original_word_representation": "dose, risk, survivors, pediatric, rt, children, radiation, gy, years, radiation dose, age, effects, ci, data, toxicity, cancer, rbe, patients, normal tissue, crt, therapy, growth, normal, late, tissue, doses, radiation therapy, rt dose, treatment, clinic, review, treated, hl, proton, exposure, chemotherapy, follow, risks, doses gy, incidence, cranial, received, increased, techniques, central, spine, modeling, dose response, relationships, systematic", "Best Fit Slope": 0.11888111888111888, "Intercepts": -236.7948717948718}, {"topic_id": 33, "Total Count": 34, "2023": 6, "2024": 1, "2022": 2, "2021": 4, "2020": 1, "2019": 2, "2018": 3, "2017": 3, "2016": 6, "2015": 2, "2014": 1, "2013": 3, "Topic": 34, "GPT_Name": "Brain Radiation Effects on Neurocognitive Outcomes", "original_word_representation": "brain, mice, cognitive, rt, changes, irradiation, dose, radiation, diffusion, imaging, white, ir, cranial, decline, injury, effects, age, volume, left, brain tumors, regions, male, biomarkers, magnetic resonance, magnetic, resonance, induced, fractionated, months, patients, damage, resonance imaging, increased, irradiated, post rt, change, radiation dose, temporal, post, functions, pediatric, loss, radiation induced, mri, development, female, long, associated, right, mean", "Best Fit Slope": 0.02097902097902098, "Intercepts": -39.51282051282051}, {"topic_id": 34, "Total Count": 35, "2023": 4, "2024": 3, "2022": 2, "2021": 1, "2020": 2, "2019": 2, "2018": 2, "2017": 4, "2016": 1, "2015": 3, "2014": 4, "2013": 7, "Topic": 35, "GPT_Name": "Head Neck IMRT Quality Assurance Outcomes", "original_word_representation": "quality, radiation, quality assurance, assurance, radiation oncology, errors, treatment, oncology, process, plan, error, review, patients, protocol, therapy, major, radiation therapy, program, cases, rt, patient, deviations, events, site, plans, compliance, planning, software, centers, time, reported, safety, clinical, systems, measures, procedures, group, care, data, physicians, severity, reporting, event, toxicity, vs, number, reports, improve, external, sites", "Best Fit Slope": -0.1993006993006993, "Intercepts": 405.20512820512823}, {"topic_id": 35, "Total Count": 34, "2023": 6, "2024": 0, "2022": 2, "2021": 7, "2020": 2, "2019": 3, "2018": 3, "2017": 0, "2016": 1, "2015": 2, "2014": 2, "2013": 6, "Topic": 36, "GPT_Name": "Targeted Radiosensitizers for Head and Neck Cancer Outcomes", "original_word_representation": "dna, cell, ir, cells, dna damage, damage, repair, lines, cell lines, cell cycle, tumor, inhibitors, cycle, assays, radiation, induced, inhibition, xenograft, clonogenic, kinase, agents, effects, dependent, tumor growth, g2, growth, assay, vitro, response, human, inhibitor, h2ax, vivo, protein, radiosensitivity, radioresistance, cancer, rt, expression, normal, nsclc, small, irradiation, models, invivo, targeting, drug, preclinical, mouse, ionizing", "Best Fit Slope": 0.02097902097902099, "Intercepts": -39.51282051282053}, {"topic_id": 36, "Total Count": 31, "2023": 0, "2024": 0, "2022": 2, "2021": 2, "2020": 1, "2019": 6, "2018": 6, "2017": 2, "2016": 2, "2015": 3, "2014": 3, "2013": 4, "Topic": 37, "GPT_Name": "IMRT for Sarcoma Toxicity and Survival", "original_word_representation": "rt, patients, local, sarcoma, surgery, os, resection, soft, soft tissue, lc, survival, preoperative, recurrence, year, local control, treatment, local recurrence, lr, tissue, median, control, complications, radiation, analysis, grade, ci, therapy, overall, treated, adjuvant, overall survival, years, postoperative, imrt, radiation therapy, tumor, margin, margins, gy, relapse, vs, disease, arm, associated, rates, toxicity, median dose, year local, free survival, prognostic", "Best Fit Slope": -0.28321678321678323, "Intercepts": 574.2564102564103}, {"topic_id": 37, "Total Count": 31, "2023": 8, "2024": 3, "2022": 3, "2021": 3, "2020": 1, "2019": 2, "2018": 0, "2017": 1, "2016": 2, "2015": 3, "2014": 4, "2013": 1, "Topic": 38, "GPT_Name": "Radiation Therapy Nonadherence and Cancer Survival Disparities", "original_word_representation": "rt, access, cancer, patients, radiation, care, therapy, geographic, radiation therapy, non, treatment, services, facility, countries, odds, facilities, patient, income, diagnosis, population, race, oncologists, ci, factors, distance, insurance, states, time, oncology, associated, likely, centers, malignancies, data, health, estimates, cancer treatment, study, rate, center, radiotherapy, multivariable, needs, odds ratio, regression, receipt, overall, courses, decreased, vs", "Best Fit Slope": 0.22727272727272727, "Intercepts": -456.1666666666667}, {"topic_id": 38, "Total Count": 33, "2023": 0, "2024": 1, "2022": 0, "2021": 0, "2020": 0, "2019": 7, "2018": 7, "2017": 0, "2016": 2, "2015": 6, "2014": 4, "2013": 6, "Topic": 39, "GPT_Name": "Alleviating Radiation Therapy Toxicity in Breast and Head and Neck Cancer", "original_word_representation": "dna, cells, repair, h2ax, foci, radiation, induced, assay, damage, radiosensitivity, cell, response, irradiation, double strand, strand, dna damage, hours, double, irradiated, high, low, formation, breaks, stem, patients, ionizing, skin, rays, ionizing radiation, oral, doses, protein, normal, ir, cellular, radiation induced, protons, g2, dose, healthy, blood, immunofluorescence, mucositis, toxicity, human, exposed, mouse, low dose, mice, mechanism", "Best Fit Slope": -0.5, "Intercepts": 1012.0}, {"topic_id": 39, "Total Count": 31, "2023": 5, "2024": 0, "2022": 2, "2021": 2, "2020": 3, "2019": 2, "2018": 4, "2017": 3, "2016": 0, "2015": 1, "2014": 4, "2013": 5, "Topic": 40, "GPT_Name": "Proton Therapy for Pediatric Glioma Survival and Toxicity", "original_word_representation": "rt, years, patients, children, pediatric, median, survival, radiation, gy, chemotherapy, range years, range, tumor, year, years range, therapy, age, received, resection, os, grade, progression, intracranial, dose, tumors, spinal, proton, surgery, pediatric patients, ci, radiation therapy, follow, treated, photon, outcomes, cord, reirradiation, irradiation, free, overall, overall survival, induction chemotherapy, respectively, brain, median age, incidence, conformal, secondary, spinal cord, time", "Best Fit Slope": -0.10839160839160839, "Intercepts": 221.37179487179486}, {"topic_id": 40, "Total Count": 47, "2023": 10, "2024": 1, "2022": 6, "2021": 10, "2020": 5, "2019": 3, "2018": 4, "2017": 1, "2016": 1, "2015": 2, "2014": 1, "2013": 3, "Topic": 41, "GPT_Name": "Radiation Immunotherapy for Tumor Control and Survival", "original_word_representation": "cells, tumor, immune, rt, cell, antitumor, anti, cd8, tumors, pd, mice, combination, radiation, irradiation, growth, tumor growth, expression, induced, activation, infiltration, irradiated, mediated, therapy, effect, mouse, dose, flow cytometry, cytometry, model, cancer, flow, therapeutic, activated, days, inhibition, immunotherapy, efficacy, microenvironment, high dose, lung, combined, melanoma, high, radiation therapy, significantly, murine, primary, vivo, effects, derived", "Best Fit Slope": 0.5, "Intercepts": -1005.3333333333334}, {"topic_id": 41, "Total Count": 31, "2023": 1, "2024": 0, "2022": 3, "2021": 3, "2020": 3, "2019": 3, "2018": 5, "2017": 2, "2016": 1, "2015": 2, "2014": 4, "2013": 4, "Topic": 42, "GPT_Name": "IMRT Dose to SVZ and Glioblastoma Survival", "original_word_representation": "glioblastoma, tumor, imaging, mri, magnetic resonance, magnetic, resonance, dose, brain, progression, patients, volumes, rt, pet, resonance imaging, newly, model, met, pfs, contrast, survival, features, therapy, newly diagnosed, radiation, treatment, using, prediction, based, glioma, diagnosed, location, areas, cm, images, normal, radiation therapy, recurrent, metabolic, planning, chemoradiation, study, enhanced, mr, recurrence, diffusion, obtained, patients newly, novel, target", "Best Fit Slope": -0.1853146853146853, "Intercepts": 376.64102564102564}, {"topic_id": 42, "Total Count": 47, "2023": 7, "2024": 0, "2022": 5, "2021": 6, "2020": 4, "2019": 2, "2018": 2, "2017": 0, "2016": 6, "2015": 6, "2014": 4, "2013": 5, "Topic": 43, "GPT_Name": "Radiation Sensitization for Improved Tumor Control", "original_word_representation": "cells, cell, hcc, cell lines, lines, expression, radioresistance, dna, radiation, inhibition, induced, radiosensitivity, apoptosis, signaling, kinase, resistance, cancer, cancer cells, human, clonogenic, dna damage, repair, tumor, assay, combination, damage, protein, breast, invitro, pathway, breast cancer, xenograft, radiation induced, h2ax, assays, gene, nsclc, effect, treatment, therapy, inhibitor, survival, pathways, role, ir, tumor cells, western, activation, formation, proliferation", "Best Fit Slope": -0.08041958041958042, "Intercepts": 166.24358974358972}, {"topic_id": 43, "Total Count": 37, "2023": 3, "2024": 1, "2022": 2, "2021": 2, "2020": 3, "2019": 3, "2018": 4, "2017": 4, "2016": 3, "2015": 7, "2014": 3, "2013": 2, "Topic": 44, "GPT_Name": "Cervical Cancer Image Guided Brachytherapy Outcomes", "original_word_representation": "brachytherapy, mri, cervical, cervical cancer, bt, patients, guided, cancer, magnetic, volume, magnetic resonance, resonance, ct, imaging, dose, clinical, advanced cervical, image, tumor, resonance imaging, stage, high, ebrt, survival, advanced, local, hdr, imaging mri, image guided, target, risk, based, interstitial, control, iva, external, gy, disease, adaptive, international, clinical target, treatment, high risk, gtv, target volume, cm, ctv, local control, planning, locally advanced", "Best Fit Slope": -0.19230769230769232, "Intercepts": 391.2564102564103}, {"topic_id": 44, "Total Count": 27, "2023": 0, "2024": 1, "2022": 2, "2021": 3, "2020": 5, "2019": 2, "2018": 4, "2017": 0, "2016": 3, "2015": 2, "2014": 3, "2013": 2, "Topic": 45, "GPT_Name": "Radiation Immunotherapy for Melanoma Response", "original_word_representation": "melanoma, lung, radiation, immune, therapy, rt, cells, mice, radiation therapy, immunotherapy, sbrt, patients, combination, irradiation, dose, fibrosis, induced, response, metastatic, studies, damage, sabr, stereotactic, gy, inhibitors, metastasis, irradiated, preclinical, cell, responses, ablative, fractionated, radiation induced, increased, tumor, local, treatment, disease, pneumonitis, clinical, systemic, cd8, body, activation, genes, effects, body radiation, stereotactic body, samples, treated", "Best Fit Slope": -0.08741258741258741, "Intercepts": 178.69230769230768}, {"topic_id": 45, "Total Count": 39, "2023": 1, "2024": 1, "2022": 1, "2021": 8, "2020": 7, "2019": 3, "2018": 2, "2017": 3, "2016": 3, "2015": 5, "2014": 5, "2013": 0, "Topic": 46, "GPT_Name": "Radiation Oncology Resident Contouring Accuracy Outcomes", "original_word_representation": "oncology, radiation oncology, medical, residents, education, radiation, ro, training, survey, educational, oncologists, resident, participants, knowledge, residency, radiation oncologists, learning, completed, physics, programs, program, care, academic, respondents, participated, opportunities, practice, states, exposure, reported, pre, health, course, united states, experience, physicians, united, year, oncologist, based, clinical, level, physicists, search, study, strongly, response rate, articles, experiences, assessment", "Best Fit Slope": -0.05244755244755245, "Intercepts": 109.11538461538461}, {"topic_id": 46, "Total Count": 26, "2023": 2, "2024": 0, "2022": 0, "2021": 0, "2020": 0, "2019": 1, "2018": 2, "2017": 3, "2016": 4, "2015": 2, "2014": 6, "2013": 6, "Topic": 47, "GPT_Name": "Proton Therapy for Melanoma Local Control and Toxicity", "original_word_representation": "melanoma, patients, visual, tumor, local, dose, mm, treated, proton, survival, control, treatment, months, follow, gy, toxicity, recurrence, planning, rate, years, brachytherapy, local control, proton therapy, mean, local recurrence, risk, therapy, rates, volume, rbe, median, patients treated, free survival, distance, radiation, tumors, used, free, dose volume, analysis, patient, year, posterior, treatment planning, mri, case, tumor recurrence, recurrences, temporal, range", "Best Fit Slope": -0.5104895104895105, "Intercepts": 1032.5897435897436}, {"topic_id": 47, "Total Count": 26, "2023": 1, "2024": 0, "2022": 5, "2021": 3, "2020": 5, "2019": 4, "2018": 1, "2017": 3, "2016": 1, "2015": 2, "2014": 0, "2013": 1, "Topic": 48, "GPT_Name": "Prostate Radiation and ADT Survival**", "original_word_representation": "adt, prostate, rt, prostate cancer, pca, psa, androgen, hormone, patients, ci, men, months, therapy, deprivation, androgen deprivation, years, risk, cancer, biochemical, deprivation therapy, randomized, term, ml, hr, radiation, trial, specific antigen, specific, localized, arm, prostate specific, vs, salvage, group, ng, radiation therapy, os, antigen, median, intermediate, duration, survival, localized prostate, follow, high risk, therapy adt, study, versus, long term, failure", "Best Fit Slope": 0.13286713286713292, "Intercepts": -266.0256410256411}, {"topic_id": 48, "Total Count": 29, "2023": 6, "2024": 0, "2022": 2, "2021": 4, "2020": 3, "2019": 6, "2018": 1, "2017": 1, "2016": 2, "2015": 1, "2014": 3, "2013": 0, "Topic": 49, "GPT_Name": "Cost of Hypofractionated Radiation Therapy for Breast and Prostate Cancer", "original_word_representation": "care, radiation, medicare, cost, ro, services, costs, income, countries, oncology, radiation oncology, radiation therapy, rt, cancer, therapy, population, health care, facilities, health, technical, access, treatment, international, medical, national, radiation oncologists, centers, oncologists, total, patient, sbrt, available, patients, units, adjusted, practices, capacity, breast, patients cancer, center, low, arm, new, model, recommendations, need, use, resources, state, cases", "Best Fit Slope": 0.19230769230769235, "Intercepts": -385.75641025641033}, {"topic_id": 49, "Total Count": 26, "2023": 1, "2024": 0, "2022": 1, "2021": 5, "2020": 3, "2019": 3, "2018": 5, "2017": 1, "2016": 2, "2015": 3, "2014": 2, "2013": 0, "Topic": 50, "GPT_Name": "Single-Fraction Radiation for Bone Metastases Outcomes", "original_word_representation": "bone, bone metastases, metastases, use, rt, fraction, patients, single fraction, radiation, single, therapy, palliative, cancer, utilization, radiation therapy, sbrt, practice, courses, data, treated, identified, guideline, life, patients treated, based, metastasis, evidence, sites, intervention, fractions, clinical, center, rate, demonstrate, significant, proportion, exposure, commonly, oncologists, ebrt, range, higher, treatment, population based, centers, younger, population, management, randomly, relatively", "Best Fit Slope": -0.013986013986013974, "Intercepts": 30.397435897435873}, {"topic_id": 50, "Total Count": 27, "2023": 0, "2024": 0, "2022": 3, "2021": 0, "2020": 4, "2019": 5, "2018": 1, "2017": 4, "2016": 1, "2015": 3, "2014": 2, "2013": 4, "Topic": 51, "GPT_Name": "Radiation and Chemotherapy for Glioma Survival", "original_word_representation": "glioma, survival, rt, patients, os, pfs, progression, grade, recurrent, high grade, radiation, progression free, tumor, median, free, free survival, dose, overall survival, reirradiation, sex, ci, age, radiation therapy, therapy, year, high, ctv, respectively, children, brain, months, overall, gy, failure, years, molecular, year os, cohort, associated, volume, mg, treated, factors, study, weeks, included, malignant, imaging, fractions, initial", "Best Fit Slope": -0.2202797202797203, "Intercepts": 446.8846153846154}, {"topic_id": 51, "Total Count": 25, "2023": 1, "2024": 0, "2022": 2, "2021": 4, "2020": 1, "2019": 1, "2018": 5, "2017": 4, "2016": 1, "2015": 2, "2014": 4, "2013": 0, "Topic": 52, "GPT_Name": "Radiation Oncology Clinical Trial Enrollment Barriers", "original_word_representation": "trials, oncology, radiation oncology, research, radiation, clinical trials, clinical, challenges, trial, practice, medicine, therapy, radiation therapy, studies, review, drug, care, development, patients, phase, cancer, areas, precision, current, american, future, national, reporting, countries, evidence, help, value, technology, issues, provided, data, time, treatment, use, safety, developing, nrg, income, enrolled, physicists, framework, self, information, vs, new", "Best Fit Slope": -0.08741258741258741, "Intercepts": 178.52564102564102}, {"topic_id": 52, "Total Count": 23, "2023": 4, "2024": 0, "2022": 0, "2021": 3, "2020": 1, "2019": 1, "2018": 3, "2017": 3, "2016": 0, "2015": 3, "2014": 2, "2013": 3, "Topic": 53, "GPT_Name": "Neoadjuvant Chemoradiation Response in Rectal Cancer", "original_word_representation": "rectal cancer, rectal, crt, patients, response, neoadjuvant, cancer, preoperative, survival, tumor, regression, chemoradiation, apoptosis, pcr, model, chemoradiation therapy, mri, locally advanced, genes, locally, cells, mr, disease free, expression, colorectal, pathologic, treatment, advanced, therapy, validation, predictive, significantly, associated, using, dna, radiosensitivity, specimens, positive, prediction, radiation, ci, step, sensitivity, showed, value, free survival, status, free, biomarker, patients locally", "Best Fit Slope": -0.1013986013986014, "Intercepts": 206.5897435897436}, {"topic_id": 53, "Total Count": 27, "2023": 2, "2024": 0, "2022": 4, "2021": 2, "2020": 0, "2019": 3, "2018": 4, "2017": 0, "2016": 4, "2015": 2, "2014": 3, "2013": 3, "Topic": 54, "GPT_Name": "Radiation Enteritis Toxicity in Cervical Cancer", "original_word_representation": "mice, induced, irradiation, expression, radiation, cells, radiation induced, cell, protein, signaling, role, injury, gy, effects, proliferation, mouse, damage, irradiated, tissues, gi, lines, body, pathway, tumor, human, inflammatory, weight, reduced, inhibitor, activation, increased, cell lines, assay, fractionated, activity, body irradiation, mucositis, inhibition, apoptosis, levels, receptor, normal, exposed, type, oral, hpv, significantly, development, gastrointestinal, tissue", "Best Fit Slope": -0.13636363636363635, "Intercepts": 277.5}, {"topic_id": 54, "Total Count": 25, "2023": 3, "2024": 0, "2022": 1, "2021": 3, "2020": 0, "2019": 5, "2018": 2, "2017": 1, "2016": 4, "2015": 1, "2014": 2, "2013": 3, "Topic": 55, "GPT_Name": "TBI Dose, Fractionation, and Toxicity Outcomes", "original_word_representation": "dose, patients, gy, transplantation, gland, incidence, acute, lung, relapse, pulmonary, irradiation, risk, total, total body, body irradiation, regimens, radiation, age, rate, pediatric, median, lung dose, dose rate, doses, imrt, years, radiation dose, associated, children, follow, stem cell, stem, marrow, group, free, undergoing, mean, analysis, year, function, rates, rt, body, rp, months, cell, cumulative incidence, data, volume, therapy", "Best Fit Slope": -0.10139860139860139, "Intercepts": 206.75641025641025}, {"topic_id": 55, "Total Count": 24, "2023": 0, "2024": 0, "2022": 1, "2021": 3, "2020": 3, "2019": 3, "2018": 2, "2017": 1, "2016": 1, "2015": 3, "2014": 3, "2013": 4, "Topic": 56, "GPT_Name": "Pediatric Rhabdomyosarcoma Local Control and Late Toxicity", "original_word_representation": "patients, local, years, failure, survival, median, cm, disease, children, therapy, risk, group, nodal, tumors, year, treated, proton, local control, pediatric, age, range, control, vs, local failure, rt, site, treatment, proton therapy, radiation therapy, radiation, free survival, dose, free, local therapy, histology, age years, overall survival, median age, tumor, os, primary, regional, pediatric patients, overall, received, diagnosis, rates, outcomes, high, years patients", "Best Fit Slope": -0.23776223776223776, "Intercepts": 481.9230769230769}, {"topic_id": 56, "Total Count": 28, "2023": 5, "2024": 2, "2022": 3, "2021": 3, "2020": 1, "2019": 1, "2018": 2, "2017": 2, "2016": 3, "2015": 1, "2014": 2, "2013": 3, "Topic": 57, "GPT_Name": "Lung Radiation: Tumor Control, Survival, and Fibrosis", "original_word_representation": "lung, fibrosis, cells, mice, induced, radiation induced, irradiation, radiation, pulmonary, injury, irradiated, mouse, activation, expression, cell, thoracic, levels, signaling, rt, mechanisms, ir, inflammatory, days, role, protein, reduced, effect, c57bl, cardiac, molecular, tissues, mechanism, increased, lungs, tumor, therapeutic, gy, exposed, skin, staining, significantly, treatment, assessed, tissue, targeting, flow, rna, flow cytometry, severe, serum", "Best Fit Slope": 0.09090909090909093, "Intercepts": -181.16666666666669}, {"topic_id": 57, "Total Count": 22, "2023": 2, "2024": 0, "2022": 1, "2021": 1, "2020": 4, "2019": 2, "2018": 0, "2017": 3, "2016": 3, "2015": 0, "2014": 3, "2013": 3, "Topic": 58, "GPT_Name": "Adaptive Hypofractionated Radiation Therapy for Bladder Cancer", "original_word_representation": "pelvic, patients, sabr, bone, therapy, radiation, radiation therapy, median, months, bladder, rt, risk, years, ci, imrt, dose, incidence, respectively, toxicity, group, bladder cancer, ptv, gy, treated, adt, cancer, received, grade, hr, treatment, local, cm, systemic, volume, planning, studies, decreased, baseline, bed, year, used, systemic therapy, prostate, weekly, follow, acute, associated, cell carcinoma, tumors, common", "Best Fit Slope": -0.13986013986013987, "Intercepts": 284.14102564102564}, {"topic_id": 58, "Total Count": 24, "2023": 4, "2024": 0, "2022": 1, "2021": 2, "2020": 3, "2019": 1, "2018": 5, "2017": 4, "2016": 0, "2015": 1, "2014": 2, "2013": 1, "Topic": 59, "GPT_Name": "Cardiac Toxicity in Lung Cancer Radiation Therapy", "original_word_representation": "heart, cardiac, dose, lung, left, changes, patients, heart dose, radiation, volume, gy, rt, lung cancer, variables, irradiation, artery, mean, small, models, nsclc, survival, mice, model, therapy, months, crt, right, studies, wall, radiation therapy, events, cancer, increase, function, based, mortality, activity, parameters, cell lung, small cell, shift, using, risk, doses, receiving, regions, perfusion, analysis, non small, maximum dose", "Best Fit Slope": 0.03496503496503497, "Intercepts": -68.57692307692308}, {"topic_id": 59, "Total Count": 22, "2023": 0, "2024": 0, "2022": 0, "2021": 3, "2020": 0, "2019": 1, "2018": 4, "2017": 4, "2016": 0, "2015": 4, "2014": 2, "2013": 4, "Topic": 60, "GPT_Name": "Glioblastoma Radiation Therapy Survival and Toxicity", "original_word_representation": "glioblastoma, patients, rt, os, pfs, survival, newly diagnosed, newly, patients newly, diagnosed, months, median, ci, received, adjuvant, radiation, progression, historical, concurrent, therapy, dose, vs, status, aged, elderly, vs months, standard, analysis, pfs os, patients received, patients aged, course, functioning, overall, overall survival, trial, associated, improved, performance status, radiation therapy, toxicity, compared, enrolled, performance, phase, gy, arm, outcomes, median os, treatment", "Best Fit Slope": -0.3146853146853147, "Intercepts": 637.0256410256411}, {"topic_id": 60, "Total Count": 30, "2023": 2, "2024": 0, "2022": 3, "2021": 5, "2020": 9, "2019": 1, "2018": 1, "2017": 5, "2016": 2, "2015": 0, "2014": 1, "2013": 1, "Topic": 61, "GPT_Name": "Hypofractionated Radiation, Immunotherapy, Abscopal Response", "original_word_representation": "immune, rt, cells, tumor, immunotherapy, checkpoint, cell, combination, radiation, antitumor, responses, activation, response, cancer, therapy, cd8, preclinical, effects, mice, systemic, irradiated, tumor growth, clinical, pd, inhibitor, growth, anti, tumors, pathways, treatment, breast, cytometry, radiation therapy, therapeutic, potential, patients, enhance, clinical trials, trials, post, inhibitors, lung, therapy rt, microenvironment, flow, mediated, induced, expression, flow cytometry, post rt", "Best Fit Slope": 0.16083916083916083, "Intercepts": -322.15384615384613}, {"topic_id": 61, "Total Count": 24, "2023": 1, "2024": 0, "2022": 1, "2021": 1, "2020": 1, "2019": 4, "2018": 1, "2017": 3, "2016": 5, "2015": 2, "2014": 3, "2013": 2, "Topic": 62, "GPT_Name": "Cervical Brachytherapy Toxicity and OAR Sparing", "original_word_representation": "brachytherapy, dose, plans, technique, target, source, doses, calculations, using, dosimetry, cervical, cm, cervical cancer, interstitial, application, carlo, monte carlo, monte, dose rate, coverage, use, treatment, volume, ebrt, clinical, used, oar, depth, proposed, rectum, gy, patients, quality, cancer, high, calculation, planning, bladder, prostate, procedure, single, compared, study, practice, bed, oars, risk, achieved, large, rate", "Best Fit Slope": -0.24475524475524477, "Intercepts": 496.03846153846155}, {"topic_id": 62, "Total Count": 23, "2023": 2, "2024": 1, "2022": 0, "2021": 1, "2020": 0, "2019": 3, "2018": 10, "2017": 2, "2016": 4, "2015": 0, "2014": 0, "2013": 0, "Topic": 63, "GPT_Name": "Adaptive Radiation Therapy Toxicity Reduction", "original_word_representation": "data, oncology, imaging, radiation oncology, review, clinical, medicine, research, radiation, precision, trials, features, development, trial, treatment, quantitative, clinical trials, care, recommendations, cancer, information, patient, rt, sets, compliance, challenges, medical, studies, plans, image, standardized, quality, early, data sets, comprehensive, personalized, learning, approaches, tumor, therapy, changes, recommended, current, heterogeneity, group, growing, treatment plans, practice, physicists, specific", "Best Fit Slope": 0.003496503496503515, "Intercepts": -5.141025641025679}, {"topic_id": 63, "Total Count": 28, "2023": 3, "2024": 2, "2022": 2, "2021": 1, "2020": 4, "2019": 7, "2018": 1, "2017": 4, "2016": 2, "2015": 2, "2014": 0, "2013": 0, "Topic": 64, "GPT_Name": "Breast Cancer Radiation Outcomes by Age and Subtype", "original_word_representation": "breast, breast cancer, rt, women, cancer, patients, hr, adjuvant, stage, age, therapy, radiation, ci, years, associated, hormone, lumpectomy, older, treatment, receptor, early stage, early, survival, stage breast, local therapy, radiation therapy, risk, aged, surgery, positive, mastectomy, nodal, survivors, negative, regression, trial, year, use, ratio, population, local, follow, cohort, hr ci, adjuvant radiation, elderly, triple, receive, pcr, analysis", "Best Fit Slope": 0.1748251748251748, "Intercepts": -350.551282051282}, {"topic_id": 64, "Total Count": 22, "2023": 2, "2024": 1, "2022": 1, "2021": 2, "2020": 1, "2019": 2, "2018": 0, "2017": 2, "2016": 1, "2015": 1, "2014": 1, "2013": 8, "Topic": 65, "GPT_Name": "Radiation-Induced Lung Toxicity in NSCLC Patients", "original_word_representation": "rp, lung, patients, risk, radiation, dose, severe, cell, nsclc, serum, grade, irradiation, lung cancer, early, model, imaging, associated, surface, therapy, radiation therapy, pneumonitis, mean lung, lung dose, breast, pre, setup, late, response, single, analysis, iqr, non, radiation pneumonitis, images, protein, blood, expression, cancer, radiation induced, associations, reference, irradiated, ratio, fibrosis, gy, hr, samples, mean, patients non, induced", "Best Fit Slope": -0.22377622377622383, "Intercepts": 453.5256410256411}, {"topic_id": 65, "Total Count": 21, "2023": 1, "2024": 1, "2022": 2, "2021": 2, "2020": 1, "2019": 0, "2018": 0, "2017": 2, "2016": 4, "2015": 2, "2014": 3, "2013": 3, "Topic": 66, "GPT_Name": "Bone Marrow Sparing Reduces Hematologic Toxicity", "original_word_representation": "marrow, bone marrow, bone, bm, pelvic, dose, pet, imrt, patients, hematologic, cisplatin, blood, mean, volume, crt, uptake, sparing, cervical, toxicity, correlated, imaging, mice, gy, radiation, therapy, reduce, cancer, treatment, ct, images, chemotherapy, cc, tomography, particle, doses, significantly, cervical cancer, active, drug, irradiation, receiving, total, functional, differences, atlas, lower, respectively, cancer patients, treated, dose volume", "Best Fit Slope": -0.1853146853146853, "Intercepts": 375.8076923076923}, {"topic_id": 66, "Total Count": 21, "2023": 6, "2024": 0, "2022": 3, "2021": 2, "2020": 1, "2019": 0, "2018": 0, "2017": 2, "2016": 4, "2015": 1, "2014": 0, "2013": 2, "Topic": 67, "GPT_Name": "Radiation Therapy Demand and Capacity Research", "original_word_representation": "radiation oncology, oncology, radiation, ro, research, oncologists, radiation oncologists, care, medical, practice, articles, number, medicare, board, academic, practices, physicians, likely, trends, majority, framework, general, united, expected, growth, united states, analysis, health, data, database, states, field, new, society, ensure, self, utilization, time, society radiation, american society, literature, ci, health care, services, therapy, american, years, radiation therapy, survey, identified", "Best Fit Slope": 0.11538461538461539, "Intercepts": -231.15384615384616}, {"topic_id": 67, "Total Count": 20, "2023": 3, "2024": 0, "2022": 3, "2021": 3, "2020": 11, "2019": 0, "2018": 0, "2017": 0, "2016": 0, "2015": 0, "2014": 0, "2013": 0, "Topic": 68, "GPT_Name": "Radiation Treatment Interruption and Telemedicine Use", "original_word_representation": "oncology, radiation oncology, survey, patients, radiation, care, practices, reported, treatment, ro, patient, radiotherapy, services, department, use, health, practice, surveys, cancer, society, united states, american society, united, initial, states, american, rt, responses, physicians, questions, schedules, findings, access, quality, society radiation, radiation oncologists, risk, reduced, oncologists, work, impact, academic, open, recommended, disease, chest, health care, centers, ct, radiation therapy", "Best Fit Slope": 0.3356643356643357, "Intercepts": -675.8717948717949}, {"topic_id": 68, "Total Count": 21, "2023": 1, "2024": 1, "2022": 0, "2021": 1, "2020": 1, "2019": 2, "2018": 2, "2017": 3, "2016": 3, "2015": 2, "2014": 2, "2013": 3, "Topic": 69, "GPT_Name": "Cervical Cancer Chemoradiation Survival and Toxicity", "original_word_representation": "patients, cisplatin, survival, adjuvant, concurrent, ci, control, rt, os, chemoradiation, study, phase, therapy, weekly, cycles, studies, chemoradiation therapy, randomized, chemotherapy, received, efficacy, dfs, crt, cervical, mg, ci ci, cancer, regimen, radiation, disease, arm, free, overall, vs, grade, dose, advanced, group, locally advanced, patients received, toxicity, trial, locally, median, treatment, overall survival, cervical cancer, concomitant, pelvic, rate", "Best Fit Slope": -0.21328671328671328, "Intercepts": 432.2692307692308}, {"topic_id": 69, "Total Count": 18, "2023": 2, "2024": 0, "2022": 2, "2021": 1, "2020": 3, "2019": 1, "2018": 2, "2017": 2, "2016": 2, "2015": 2, "2014": 1, "2013": 0, "Topic": 70, "GPT_Name": "SBRT for Bone Metastases: Pain Relief and Survival", "original_word_representation": "pain, bone metastases, bone, sbrt, metastases, qol, patients, response, rt, group, palliative, radiation therapy, model, reirradiation, therapy, radiation, crt, response rates, months, ci, survival, scores, score, treatment, performance, life, arm, versus, studies, weeks, primary, randomized, analyses, evaluable patients, respectively, validation, single fraction, oligometastatic, rates, trial, scale, improved, oligometastatic disease, complete, primary tumor, predictors, reported, lesions, fraction, gy", "Best Fit Slope": 0.02097902097902098, "Intercepts": -40.84615384615385}, {"topic_id": 70, "Total Count": 19, "2023": 3, "2024": 0, "2022": 3, "2021": 1, "2020": 2, "2019": 0, "2018": 0, "2017": 3, "2016": 2, "2015": 1, "2014": 2, "2013": 2, "Topic": 71, "GPT_Name": "Hypofractionated Proton Therapy for Lung Cancer Survival", "original_word_representation": "proton, proton therapy, dose, patients, therapy, gy, plans, grade, stage, rbe, concurrent, chemotherapy, temporal, concurrent chemotherapy, lung, radiation, nsclc, hypofractionated, survival, months, proton beam, tumors, fraction, beam, median, lung cancer, received, pneumonitis, range, toxicity, pulmonary, radiation therapy, treatment, necrosis, clinical, imrt, patients stage, non, normal, cancer, patient, stage ii, probability, non small, iii, volume, small cell, doses, small, proton radiation", "Best Fit Slope": -0.02447552447552447, "Intercepts": 50.987179487179475}, {"topic_id": 71, "Total Count": 18, "2023": 1, "2024": 0, "2022": 1, "2021": 1, "2020": 1, "2019": 3, "2018": 2, "2017": 3, "2016": 2, "2015": 0, "2014": 2, "2013": 2, "Topic": 72, "GPT_Name": "Wilms Tumor Surgery Radiation Interval: Overall Survival\"", "original_word_representation": "rt, sites, patients, children, relapse, metastatic, disease, site, local, therapy, high risk, pediatric, primary, radiation, risk, survival, aged, control, local control, treated, high, radiation therapy, diagnosis, chemotherapy, use, age, patient, resection, tumor, follow, median, scores, stage, protocols, free, induction chemotherapy, induction, lc, year, locoregional, overall, patients high, irradiated, patients treated, treatment, overall survival, years, gross, therapy rt, surgical", "Best Fit Slope": -0.11888111888111888, "Intercepts": 241.46153846153845}, {"topic_id": 72, "Total Count": 25, "2023": 3, "2024": 0, "2022": 0, "2021": 5, "2020": 0, "2019": 7, "2018": 2, "2017": 1, "2016": 0, "2015": 2, "2014": 0, "2013": 5, "Topic": 73, "GPT_Name": "Radiation Oncologist Workforce Outcomes and Quality", "original_word_representation": "ro, oncology, radiation oncology, academic, research, radiation, respondents, survey, female, physician, program, oncologists, time, american, radiation oncologists, reported, medical, residency, gender, male, residents, american society, society radiation, annual, society, board, proportion, practice, identified, positions, number, training, men, current, online, published, increased, future, years, year, articles, radiation oncologist, oncologist, vs, decreased, health, trends, publications, data, response rate", "Best Fit Slope": -0.05244755244755244, "Intercepts": 107.94871794871793}, {"topic_id": 73, "Total Count": 24, "2023": 2, "2024": 2, "2022": 1, "2021": 5, "2020": 2, "2019": 1, "2018": 4, "2017": 1, "2016": 2, "2015": 1, "2014": 0, "2013": 3, "Topic": 74, "GPT_Name": "Prostate Proton Therapy Rectal Toxicity", "original_word_representation": "prostate, ctv, mri, contouring, guidelines, consensus, delineation, contours, prostatectomy, recommendations, volume, prostate cancer, maps, imaging, anatomic, clinical, patients, nodal, pca, atlas, biopsy, cancer, gleason, target, coverage, men, using, gleason score, volumes, radiation oncologists, oncologists, radiation, contour, nodes, regions, mm, resonance imaging, high, recurrent, level, radical prostatectomy, contoured, pelvic, magnetic resonance, magnetic, resonance, risk, positive, cases, based", "Best Fit Slope": 0.07692307692307693, "Intercepts": -153.26923076923077}, {"topic_id": 74, "Total Count": 17, "2023": 1, "2024": 0, "2022": 2, "2021": 10, "2020": 2, "2019": 0, "2018": 1, "2017": 0, "2016": 0, "2015": 1, "2014": 0, "2013": 0, "Topic": 75, "GPT_Name": "Low-dose whole-lung radiation for COVID-19 pneumonia outcomes.", "original_word_representation": "lung, days, rt, low dose, patients, low, dose, doses, clinical, disease, irradiation, studies, gy, radiation, dose radiation, day, inflammatory, blood, mice, treatment, decreased, exposure, severe, data, requiring, biological, preclinical, induced, tissues, single, randomized, risk, clinicians, mortality, risks, oxygen, single fraction, normal, therapy, normal tissues, rbe, fraction, radiation therapy, trials, survival, significant, using, beam, endpoints, range", "Best Fit Slope": 0.24825174825174826, "Intercepts": -499.6794871794872}, {"topic_id": 75, "Total Count": 17, "2023": 2, "2024": 0, "2022": 1, "2021": 0, "2020": 3, "2019": 1, "2018": 3, "2017": 2, "2016": 0, "2015": 1, "2014": 1, "2013": 3, "Topic": 76, "GPT_Name": "SRS and ICI Toxicity in Brain Metastases", "original_word_representation": "srs, metastases, brain, brain metastases, melanoma, patients, survival, bm, prognostic, wbrt, patients brain, prognostic factors, pd, factors, respectively, radiosurgery, median survival, stereotactic radiosurgery, analysis, treated, local, median, rt, status, updated, karnofsky performance, karnofsky, lung, concurrent, subtype, neurologic, number, local therapy, performance status, months, associated, inhibitors, months respectively, diagnosis, ci, therapy, breast, stereotactic, metastasis, lung cancer, checkpoint, cohorts, nsclc, performance, ii", "Best Fit Slope": -0.08041958041958042, "Intercepts": 163.74358974358972}, {"topic_id": 76, "Total Count": 23, "2023": 0, "2024": 0, "2022": 0, "2021": 0, "2020": 0, "2019": 2, "2018": 1, "2017": 3, "2016": 2, "2015": 5, "2014": 5, "2013": 5, "Topic": 77, "GPT_Name": "Pancreatic Cancer Tumor Motion Management in Radiation Therapy", "original_word_representation": "motion, mri, tumor, mm, pancreatic, markers, position, displacement, respiratory, marker, ct, patients, mm mm, directions, dimensional, pancreatic cancer, tumors, gtv, lr, method, abdominal, reference, images, cm, imaging, superior inferior, direction, image, lung, breathing, cancer patients, liver, real time, based, time, variation, real, fractions, inferior, variations, respectively, anterior posterior, surrogate, superior, right, volumes, radiation, cancer, volume, left right", "Best Fit Slope": -0.534965034965035, "Intercepts": 1081.7435897435898}, {"topic_id": 77, "Total Count": 20, "2023": 3, "2024": 0, "2022": 0, "2021": 1, "2020": 1, "2019": 0, "2018": 3, "2017": 1, "2016": 0, "2015": 4, "2014": 5, "2013": 2, "Topic": 78, "GPT_Name": "Cervical Cancer Brachytherapy Impact on Survival", "original_word_representation": "brachytherapy, patients, cervical, bt, ebrt, rt, cervical cancer, adjuvant, cancer, stage, survival, women, os, associated, treatment, received, use, ci, surgery, recurrence, insurance, mortality, pelvic, hr, propensity, chemotherapy, radiation, dfs, involvement, adjuvant rt, identified, analysis, age, risk, therapy, score, utilization, year, patient, external beam, predictor, factors, treated, overall survival, overall, substantial, external, radiation therapy, higher, lymph", "Best Fit Slope": -0.23076923076923078, "Intercepts": 467.474358974359}, {"topic_id": 78, "Total Count": 25, "2023": 3, "2024": 2, "2022": 0, "2021": 1, "2020": 1, "2019": 1, "2018": 1, "2017": 2, "2016": 5, "2015": 2, "2014": 4, "2013": 3, "Topic": 79, "GPT_Name": "Proton Radiation Skin Toxicity in Breast Cancer", "original_word_representation": "skin, breast, dermatitis, patients, toxicity, radiation, fatigue, breast cancer, pain, grade, rt, significantly, reported, chest wall, cancer, weeks, chest, severe, therapy, radiation therapy, wall, scores, containing, week, study, proton, vs, group, common, use, postmastectomy, induced, reconstruction, severity, undergoing, arm, randomized, breast radiation, odds, acute, patient reported, life, maximum, daily, adverse, late, toxicities, compared, significant, groups", "Best Fit Slope": -0.1993006993006993, "Intercepts": 404.37179487179486}, {"topic_id": 79, "Total Count": 17, "2023": 2, "2024": 0, "2022": 3, "2021": 1, "2020": 1, "2019": 2, "2018": 2, "2017": 0, "2016": 2, "2015": 0, "2014": 2, "2013": 2, "Topic": 80, "GPT_Name": "Late Toxicity of Cervical Cancer Brachytherapy", "original_word_representation": "morbidity, symptoms, brachytherapy, cervical, cervical cancer, patients, advanced cervical, hdr, treatment, events, late, gi, eortc, locally advanced, grade, functioning, cancer, locally, baseline, advanced, follow, sexual, persistent, adaptive, reported, risk, severe, pain, fatigue, rates, respectively, factors, chemotherapy, months, assessed, patient, related, time, guided, organization, european, incidence, prevalence, image guided, costs, therapy, patient reported, ebrt, physician, european organization", "Best Fit Slope": -0.010489510489510483, "Intercepts": 22.589743589743577}, {"topic_id": 80, "Total Count": 20, "2023": 0, "2024": 0, "2022": 0, "2021": 3, "2020": 1, "2019": 2, "2018": 0, "2017": 2, "2016": 3, "2015": 3, "2014": 2, "2013": 4, "Topic": 81, "GPT_Name": "Image Guided Proton Therapy for Prostate Cancer Outcomes", "original_word_representation": "rectal, prostate, prostate cancer, bleeding, bowel, toxicity, patients, grade, cancer, qol, late, rectum, reported, therapy, wall, scores, gastrointestinal, risk, proton, patient reported, significant, urinary, localized prostate, intermediate, localized, cancer index, index composite, expanded prostate, composite, toxicities, rates, low, acute, expanded, version, index, proton therapy, dose, intermediate risk, biochemical, cc, gy, patient, hypofractionated, quality life, year, men, events, group, treated", "Best Fit Slope": -0.2937062937062937, "Intercepts": 594.5128205128204}, {"topic_id": 81, "Total Count": 18, "2023": 1, "2024": 0, "2022": 1, "2021": 3, "2020": 1, "2019": 2, "2018": 1, "2017": 2, "2016": 1, "2015": 3, "2014": 3, "2013": 0, "Topic": 82, "GPT_Name": "IMRT for Breast Cancer Local Control and Toxicity", "original_word_representation": "breast, imrt, boost, dose, plans, volume, breast cancer, ptv, patients, lung, mm, heart, therapy, radiation therapy, breast radiation, modulated, lc, ipsilateral, radiation, planning, treatment, integrated boost, intensity, cosmetic, cavity, intensity modulated, planned, tissue, inverse, modulated radiation, contralateral, target, chest wall, differences, simultaneous, integrated, chest, organs, beam, wall, coverage, respectively, cancer, algorithm, adaptive, mean, vmat, margin, dimensional, crt", "Best Fit Slope": -0.08391608391608392, "Intercepts": 170.8846153846154}, {"topic_id": 82, "Total Count": 15, "2023": 1, "2024": 0, "2022": 0, "2021": 0, "2020": 3, "2019": 3, "2018": 1, "2017": 2, "2016": 1, "2015": 0, "2014": 2, "2013": 2, "Topic": 83, "GPT_Name": "Esophageal and Lung Cancer Radiation Therapy Outcomes", "original_word_representation": "patients, survival, stage, sbrt, pfs, nsclc, grade, disease, treated, arm, biomarker, treatment, definitive, therapy, rates, cancer, radiation, lung cancer, esophageal, lung, fibrosis, oligometastatic, overall, median, sabr, months, radiation therapy, failure, progression, cell, primary, esophagitis, lesions, imrt, years, overall survival, metastatic, small, cell lung, small cell, versus, primary tumor, hr, tumor, control, free survival, toxicity, distant, local therapy, trial", "Best Fit Slope": -0.10839160839160839, "Intercepts": 220.03846153846152}, {"topic_id": 83, "Total Count": 17, "2023": 5, "2024": 0, "2022": 2, "2021": 4, "2020": 2, "2019": 0, "2018": 2, "2017": 0, "2016": 1, "2015": 0, "2014": 1, "2013": 0, "Topic": 84, "GPT_Name": "Radiation Immunotherapy for Lung Cancer Survival and Toxicity", "original_word_representation": "patients, pfs, lung, cell, os, lung cancer, nsclc, grade, cell lung, rt, small cell, small, response, dose, ci, immune, months, radiation, therapy, metastatic, sbrt, immunotherapy, pfs os, biomarkers, progression, tumor, median, cancer, phase, survival, sabr, median pfs, checkpoint, non small, blood, genes, associated, pd, toxicity, rp, pulmonary, gy, study, safety, crt, adverse, progression free, non, reached, disease", "Best Fit Slope": 0.2412587412587413, "Intercepts": -485.56410256410265}, {"topic_id": 84, "Total Count": 17, "2023": 2, "2024": 1, "2022": 1, "2021": 0, "2020": 5, "2019": 2, "2018": 1, "2017": 0, "2016": 0, "2015": 2, "2014": 0, "2013": 3, "Topic": 85, "GPT_Name": "Total Body Irradiation Hematopoietic Recovery and Survival", "original_word_representation": "cells, ir, marrow, irradiation, mice, irradiated, recovery, cell, human, radiation, bone marrow, stem, blood, induced, bm, bone, expression, dose, exposure, damage, apoptosis, cellular, injury, body irradiation, response, dna, body, total body, immune, acute, radiation induced, gy, activation, dose radiation, tissue, skin, dna damage, hours, administration, marker, vascular, stem cell, syndrome, treatment, total, mouse, populations, signaling, transplantation, tissues", "Best Fit Slope": 0.017482517482517484, "Intercepts": -33.871794871794876}, {"topic_id": 85, "Total Count": 19, "2023": 0, "2024": 0, "2022": 0, "2021": 1, "2020": 1, "2019": 1, "2018": 4, "2017": 4, "2016": 4, "2015": 1, "2014": 0, "2013": 3, "Topic": 86, "GPT_Name": "High-Dose Proton Therapy for Chordoma Local Control", "original_word_representation": "rbe, patients, local, median, survival, proton, local control, control, proton therapy, range, carbon, gy, dose, grade, therapy, tumor, progression, years, surgery, overall survival, relative biological, effectiveness, disease, free survival, overall, free, toxicity, relative, radiation, biological effectiveness, follow, biological, tumors, year, carbon ion, gy relative, effectiveness rbe, range gy, ion, local progression, spinal, high, received, months, age, rates, progression free, treated, reirradiation, scanning", "Best Fit Slope": -0.23426573426573427, "Intercepts": 474.44871794871796}, {"topic_id": 86, "Total Count": 16, "2023": 0, "2024": 0, "2022": 0, "2021": 1, "2020": 1, "2019": 0, "2018": 2, "2017": 11, "2016": 0, "2015": 0, "2014": 0, "2013": 1, "Topic": 87, "GPT_Name": "Elderly Head Neck Cancer Outcomes with Radiation Therapy", "original_word_representation": "elderly, patients, age, os, aged, cancer, neck, older, patients aged, therapy, survival, adjuvant, head neck, hpv, head, treatment, younger, associated, comorbidity, association, surgery, radiation, status, population, hr, adverse, cohort, score, radiation therapy, neck cancer, cohorts, odds, care, treatment related, ratio, definitive, performance status, toxicity, compared, related, chemoradiation, events, confidence interval, confidence, esophageal cancer, interval, ratio confidence, assessed, chemoradiotherapy, risk", "Best Fit Slope": -0.13286713286713286, "Intercepts": 269.525641025641}, {"topic_id": 87, "Total Count": 15, "2023": 0, "2024": 1, "2022": 3, "2021": 1, "2020": 3, "2019": 2, "2018": 0, "2017": 2, "2016": 1, "2015": 1, "2014": 1, "2013": 0, "Topic": 88, "GPT_Name": "Prostate SBRT Toxicity and Quality of Life", "original_word_representation": "pet, prostate, pet ct, ct, prostate cancer, patients, men, imaging, arm, prostate specific, toxicity, antigen, gy, lesions, detection, cancer, cohort, disease, biopsy, ctv, grade, specific, high, oligometastatic, dose, gu, detected, gi, targeted, ml, recurrence, relapse, biochemical, mri, risk, high risk, psa, therapy, contours, specific antigen, tomography, standard, positive, volumes, accuracy, genitourinary, group, focal, analysis, study", "Best Fit Slope": 0.07342657342657342, "Intercepts": -146.96153846153845}, {"topic_id": 88, "Total Count": 17, "2023": 3, "2024": 0, "2022": 1, "2021": 3, "2020": 2, "2019": 0, "2018": 0, "2017": 1, "2016": 1, "2015": 2, "2014": 0, "2013": 4, "Topic": 89, "GPT_Name": "Hippocampal Avoidance PCI for Lung Cancer NCF", "original_word_representation": "brain, patients, wbrt, decline, metastases, brain metastases, scores, months, cognitive, function, delayed, model, cranial, baseline, test, rt, patients brain, avoidance, associated, rtog, bm, prophylactic, adult, irradiation, testing, learning, functioning, symptoms, association, self, data, reported, treatment, trial, brain tumors, using, cost, survival, group, ci, treated, lung cancer, brain radiation, radiation, time, observation, enrolled, qol, primary, life", "Best Fit Slope": -0.03846153846153846, "Intercepts": 79.05128205128204}, {"topic_id": 89, "Total Count": 14, "2023": 0, "2024": 0, "2022": 1, "2021": 2, "2020": 1, "2019": 0, "2018": 2, "2017": 2, "2016": 1, "2015": 1, "2014": 0, "2013": 4, "Topic": 90, "GPT_Name": "Breast Cancer Partial Breast Irradiation Outcomes", "original_word_representation": "breast, mri, patients, preoperative, partial breast, breast irradiation, breast cancer, risk, partial, response, tumor, accelerated partial, irradiation, years, breast conserving, eligibility, conserving, accelerated, vs, conserving surgery, suitable, grade, risk factors, complete, recurrence, cancer, radiation, women, number, invasive, surgery, complete response, numbers, ipsilateral, low risk, treated, imaging, based, cc, cohort, range, lc, pet ct, low, features, median, situ, magnetic resonance, magnetic, resonance", "Best Fit Slope": -0.15384615384615385, "Intercepts": 311.70512820512823}, {"topic_id": 90, "Total Count": 17, "2023": 9, "2024": 0, "2022": 1, "2021": 0, "2020": 1, "2019": 2, "2018": 1, "2017": 0, "2016": 1, "2015": 0, "2014": 1, "2013": 1, "Topic": 91, "GPT_Name": "Gender Experiences in Radiation Oncology Programs", "original_word_representation": "ro, residents, medical, radiation oncology, women, gender, oncology, experiences, survey, program, female, programs, reported, inclusion, physicists, medicine, residency, radiation, sexual, efforts, opportunities, department, respondents, race, physicians, academic, american, resident, support, association, physics, review, united states, united, increased, states, current, participants, lack, male, general, groups, remain, based, response rate, having, society, selection, education, clinical trials", "Best Fit Slope": 0.23426573426573427, "Intercepts": -471.44871794871796}, {"topic_id": 91, "Total Count": 19, "2023": 3, "2024": 0, "2022": 0, "2021": 3, "2020": 1, "2019": 4, "2018": 0, "2017": 2, "2016": 0, "2015": 0, "2014": 2, "2013": 4, "Topic": 92, "GPT_Name": "Proton RBE and Temporal Lobe Enhancement**", "original_word_representation": "proton, insurance, patients, proton therapy, therapy, pediatric, centers, proton beam, patient, imrt, photon, coverage, treatment, prostate, radiation, medicare, cancer, beam, beam therapy, number, clinical, center, search, malignancies, cases, utilization, studies, trials, compared, increased, pediatric patients, dose, rates, quality, initial, protons, start, relative, require, pca, breast, evaluated, rt, prostate cancer, ci, median, information, head neck, expected, study", "Best Fit Slope": -0.06643356643356643, "Intercepts": 135.67948717948718}, {"topic_id": 92, "Total Count": 15, "2023": 3, "2024": 0, "2022": 0, "2021": 2, "2020": 0, "2019": 4, "2018": 1, "2017": 0, "2016": 0, "2015": 1, "2014": 2, "2013": 2, "Topic": 93, "GPT_Name": "Breast Cancer Regional Nodal Irradiation Lymphedema Risk", "original_word_representation": "axillary, risk, breast, lymph, breast cancer, nodal, node, radiation, lymph node, surgery, arm, patients, regional, factors, gy, risk factors, dissection, regional nodal, level, nodal irradiation, nodes, ii, rt, dose, cancer, therapy, lymph nodes, radiation therapy, cgy, development, women, hr, associated, irradiation, ci, incidence, model, received, multivariable, upper, median, fields, field, vs, index, extensive, lateral, mass, treatment, biopsy", "Best Fit Slope": -0.024475524475524476, "Intercepts": 50.65384615384615}, {"topic_id": 93, "Total Count": 18, "2023": 1, "2024": 1, "2022": 3, "2021": 1, "2020": 2, "2019": 1, "2018": 1, "2017": 2, "2016": 1, "2015": 2, "2014": 1, "2013": 2, "Topic": 94, "GPT_Name": "Reirradiation for Recurrent Cervical Cancer Survival", "original_word_representation": "cervical cancer, cervical, patients, crt, os, hr, cancer, survival, stage, recurrence, factors, relapse, ci, rt, staging, year, analysis, univariate, chemoradiation, radiation, median, included, outcomes, overall, multivariate, prognostic, therapy, adjuvant, toxicity, vs, predictive, chemotherapy, iva, associated, months, hazard, overall survival, expression, cgy, univariate analysis, dfs, definitive, distant, women, pelvic, os patients, international, treatment, type, concurrent", "Best Fit Slope": -0.013986013986013986, "Intercepts": 29.73076923076923}, {"topic_id": 94, "Total Count": 15, "2023": 0, "2024": 0, "2022": 3, "2021": 1, "2020": 1, "2019": 0, "2018": 0, "2017": 3, "2016": 2, "2015": 1, "2014": 3, "2013": 1, "Topic": 95, "GPT_Name": "Hypofractionated Radiation Therapy for Breast Cancer Outcomes", "original_word_representation": "breast, hypofractionation, use, hypofractionated, breast cancer, women, radiation, rt, increased, cancer, hypofractionated radiation, patients, fractionation, geographic, patient, radiation therapy, facility, therapy, states, breast radiation, care, received, pathway, united states, treatment, united, medicare, hr, conventional, age, stage breast, level, american, region, receipt, early, stage, imrt, despite, receiving, early stage, arm, shorter, multivariable, lumpectomy, breast irradiation, clinical, cost, associated, compared", "Best Fit Slope": -0.12237762237762238, "Intercepts": 248.26923076923077}, {"topic_id": 95, "Total Count": 17, "2023": 1, "2024": 0, "2022": 0, "2021": 0, "2020": 0, "2019": 2, "2018": 2, "2017": 2, "2016": 2, "2015": 3, "2014": 3, "2013": 2, "Topic": 96, "GPT_Name": "Liver SBRT Respiratory Motion Toxicity Reduction", "original_word_representation": "motion, mri, liver, respiratory, mm, images, image, dimensional, imaging, reconstruction, using, acquisition, method, tracking, tumor, directions, breathing, acquired, magnetic resonance, magnetic, resonance, resolution, surrogate, based, resonance imaging, correlation, t2, sequence, accuracy, technique, mr, respectively, study, simulation, internal, weighted, mm mm, healthy, used, phase, signal, subject, cc, mean, board, scans, data, superior inferior, ct, proposed", "Best Fit Slope": -0.2692307692307692, "Intercepts": 544.8589743589743}, {"topic_id": 96, "Total Count": 15, "2023": 1, "2024": 1, "2022": 3, "2021": 1, "2020": 0, "2019": 2, "2018": 2, "2017": 1, "2016": 1, "2015": 2, "2014": 1, "2013": 0, "Topic": 97, "GPT_Name": "Proton Therapy for Sarcoma Local Control and Toxicity", "original_word_representation": "sarcoma, local, rt, patients, hr, tumors, os, lc, local therapy, local failure, incidence, failure, survival, control, associated, chemotherapy, local control, years, median, year, therapy, tumor, disease, radiation, range, spine, acute, treated, adapted, diagnosis, initiation, pelvis, dose, metastases, toxic, cumulative, risk, pediatric, surgery, progression, hazard ratio, ratio, pulmonary, versus, hazard, vs, outcomes, distant, pediatric patients, free survival", "Best Fit Slope": 0.05244755244755245, "Intercepts": -104.61538461538461}, {"topic_id": 97, "Total Count": 15, "2023": 1, "2024": 0, "2022": 2, "2021": 2, "2020": 1, "2019": 1, "2018": 1, "2017": 1, "2016": 2, "2015": 0, "2014": 3, "2013": 1, "Topic": 98, "GPT_Name": "Radiation for NSCLC Brain Metastases Survival and Control", "original_word_representation": "bm, brain, wbrt, patients, pd, nsclc, brain metastases, survival, metastases, srs, os, intracranial, progression, group, kinase, expression, ci, lung, hr, non, overall, overall survival, rt, received, cranial, cell lung, small cell, lung cancer, vs, growth factor, therapy, cell, months, longer, factor, hr ci, arm, progression free, non small, epidermal growth, versus, epidermal, factor receptor, small, brain radiation, iii, stereotactic radiosurgery, receive, cancer nsclc, growth", "Best Fit Slope": -0.05244755244755245, "Intercepts": 107.11538461538461}, {"topic_id": 98, "Total Count": 15, "2023": 2, "2024": 1, "2022": 0, "2021": 1, "2020": 2, "2019": 3, "2018": 1, "2017": 1, "2016": 2, "2015": 1, "2014": 0, "2013": 1, "Topic": 99, "GPT_Name": "Postmastectomy Breast Cancer Radiation Outcomes", "original_word_representation": "reconstruction, breast, mastectomy, patients, breast cancer, radiation, skin, women, postmastectomy, axillary, cost, therapy, group, lr, risk, cumulative incidence, local, recurrence, failure, radiation therapy, cancer, treated, incidence, node, years, vs, ci, cumulative, boost, age, use, complications, chest, mortality, survival, stage, breast irradiation, rate, chest wall, randomized, compared, positive, local failure, ir, locoregional, patients treated, trials, wall, median, neoadjuvant", "Best Fit Slope": 0.038461538461538464, "Intercepts": -76.38461538461539}, {"topic_id": 99, "Total Count": 14, "2023": 2, "2024": 0, "2022": 2, "2021": 3, "2020": 2, "2019": 1, "2018": 1, "2017": 2, "2016": 0, "2015": 1, "2014": 0, "2013": 0, "Topic": 100, "GPT_Name": "Patient-Reported Outcomes in Radiation Therapy Toxicity", "original_word_representation": "reported, trials, patient, patients, patient reported, symptoms, toxicity, electronic, data, reporting, self, cancer, adverse, adverse events, rt, quality, treatment, reported outcomes, events, radiation, symptom, assessment, research, quality life, symptomatic, studies, life, breast, criteria, assessments, terminology criteria, common terminology, qol, terminology, criteria adverse, national, therapy, outcomes, report, lung, patients receiving, including, patients undergoing, effects, undergoing, study, items, radiation therapy, common, acute", "Best Fit Slope": 0.13986013986013987, "Intercepts": -281.14102564102564}], "data-b862d70ba9859ace83af955ded11dbb9": [{"Year": 2013, "variable": "FLASH Proton RT Normal Tissue Radioprotection", "value": 1.0512820512822145}, {"Year": 2014, "variable": "FLASH Proton RT Normal Tissue Radioprotection", "value": 1.617715617715703}, {"Year": 2015, "variable": "FLASH Proton RT Normal Tissue Radioprotection", "value": 2.184149184149419}, {"Year": 2016, "variable": "FLASH Proton RT Normal Tissue Radioprotection", "value": 2.7505827505829075}, {"Year": 2017, "variable": "FLASH Proton RT Normal Tissue Radioprotection", "value": 3.317016317016396}, {"Year": 2018, "variable": "FLASH Proton RT Normal Tissue Radioprotection", "value": 3.883449883450112}, {"Year": 2019, "variable": "FLASH Proton RT Normal Tissue Radioprotection", "value": 4.4498834498836}, {"Year": 2020, "variable": "FLASH Proton RT Normal Tissue Radioprotection", "value": 5.016317016317089}, {"Year": 2021, "variable": "FLASH Proton RT Normal Tissue Radioprotection", "value": 5.582750582750805}, {"Year": 2022, "variable": "FLASH Proton RT Normal Tissue Radioprotection", "value": 6.149184149184293}, {"Year": 2023, "variable": "FLASH Proton RT Normal Tissue Radioprotection", "value": 6.715617715617782}, {"Year": 2024, "variable": "FLASH Proton RT Normal Tissue Radioprotection", "value": 7.282051282051498}, {"Year": 2013, "variable": "Proton Therapy for Head and Neck Cancer Survival", "value": 4.230769230769283}, {"Year": 2014, "variable": "Proton Therapy for Head and Neck Cancer Survival", "value": 4.779720279720323}, {"Year": 2015, "variable": "Proton Therapy for Head and Neck Cancer Survival", "value": 5.328671328671362}, {"Year": 2016, "variable": "Proton Therapy for Head and Neck Cancer Survival", "value": 5.8776223776224015}, {"Year": 2017, "variable": "Proton Therapy for Head and Neck Cancer Survival", "value": 6.426573426573441}, {"Year": 2018, "variable": "Proton Therapy for Head and Neck Cancer Survival", "value": 6.97552447552448}, {"Year": 2019, "variable": "Proton Therapy for Head and Neck Cancer Survival", "value": 7.52447552447552}, {"Year": 2020, "variable": "Proton Therapy for Head and Neck Cancer Survival", "value": 8.07342657342656}, {"Year": 2021, "variable": "Proton Therapy for Head and Neck Cancer Survival", "value": 8.622377622377599}, {"Year": 2022, "variable": "Proton Therapy for Head and Neck Cancer Survival", "value": 9.171328671328638}, {"Year": 2023, "variable": "Proton Therapy for Head and Neck Cancer Survival", "value": 9.720279720279677}, {"Year": 2024, "variable": "Proton Therapy for Head and Neck Cancer Survival", "value": 10.269230769230717}, {"Year": 2013, "variable": "Radiation Immunotherapy for Tumor Control and Survival", "value": 1.1666666666666288}, {"Year": 2014, "variable": "Radiation Immunotherapy for Tumor Control and Survival", "value": 1.6666666666666288}, {"Year": 2015, "variable": "Radiation Immunotherapy for Tumor Control and Survival", "value": 2.1666666666666288}, {"Year": 2016, "variable": "Radiation Immunotherapy for Tumor Control and Survival", "value": 2.6666666666666288}, {"Year": 2017, "variable": "Radiation Immunotherapy for Tumor Control and Survival", "value": 3.1666666666666288}, {"Year": 2018, "variable": "Radiation Immunotherapy for Tumor Control and Survival", "value": 3.6666666666666288}, {"Year": 2019, "variable": "Radiation Immunotherapy for Tumor Control and Survival", "value": 4.166666666666629}, {"Year": 2020, "variable": "Radiation Immunotherapy for Tumor Control and Survival", "value": 4.666666666666629}, {"Year": 2021, "variable": "Radiation Immunotherapy for Tumor Control and Survival", "value": 5.166666666666629}, {"Year": 2022, "variable": "Radiation Immunotherapy for Tumor Control and Survival", "value": 5.666666666666629}, {"Year": 2023, "variable": "Radiation Immunotherapy for Tumor Control and Survival", "value": 6.166666666666629}, {"Year": 2024, "variable": "Radiation Immunotherapy for Tumor Control and Survival", "value": 6.666666666666629}, {"Year": 2013, "variable": "IMRT for Head Neck Cancer Toxicity and Survival", "value": 36.57692307692332}, {"Year": 2014, "variable": "IMRT for Head Neck Cancer Toxicity and Survival", "value": 35.381118881119164}, {"Year": 2015, "variable": "IMRT for Head Neck Cancer Toxicity and Survival", "value": 34.18531468531501}, {"Year": 2016, "variable": "IMRT for Head Neck Cancer Toxicity and Survival", "value": 32.98951048951085}, {"Year": 2017, "variable": "IMRT for Head Neck Cancer Toxicity and Survival", "value": 31.79370629370669}, {"Year": 2018, "variable": "IMRT for Head Neck Cancer Toxicity and Survival", "value": 30.597902097902534}, {"Year": 2019, "variable": "IMRT for Head Neck Cancer Toxicity and Survival", "value": 29.40209790209792}, {"Year": 2020, "variable": "IMRT for Head Neck Cancer Toxicity and Survival", "value": 28.206293706293764}, {"Year": 2021, "variable": "IMRT for Head Neck Cancer Toxicity and Survival", "value": 27.010489510489606}, {"Year": 2022, "variable": "IMRT for Head Neck Cancer Toxicity and Survival", "value": 25.81468531468545}, {"Year": 2023, "variable": "IMRT for Head Neck Cancer Toxicity and Survival", "value": 24.61888111888129}, {"Year": 2024, "variable": "IMRT for Head Neck Cancer Toxicity and Survival", "value": 23.423076923077133}, {"Year": 2013, "variable": "Adaptive IMRT for Cervical Cancer Toxicity", "value": 12.474358974358893}, {"Year": 2014, "variable": "Adaptive IMRT for Cervical Cancer Toxicity", "value": 11.145687645687758}, {"Year": 2015, "variable": "Adaptive IMRT for Cervical Cancer Toxicity", "value": 9.817016317016169}, {"Year": 2016, "variable": "Adaptive IMRT for Cervical Cancer Toxicity", "value": 8.488344988345034}, {"Year": 2017, "variable": "Adaptive IMRT for Cervical Cancer Toxicity", "value": 7.1596736596734445}, {"Year": 2018, "variable": "Adaptive IMRT for Cervical Cancer Toxicity", "value": 5.83100233100231}, {"Year": 2019, "variable": "Adaptive IMRT for Cervical Cancer Toxicity", "value": 4.50233100233072}, {"Year": 2020, "variable": "Adaptive IMRT for Cervical Cancer Toxicity", "value": 3.1736596736595857}, {"Year": 2021, "variable": "Adaptive IMRT for Cervical Cancer Toxicity", "value": 1.844988344988451}, {"Year": 2022, "variable": "Adaptive IMRT for Cervical Cancer Toxicity", "value": 0.5163170163168616}, {"Year": 2023, "variable": "Adaptive IMRT for Cervical Cancer Toxicity", "value": -0.8123543123542731}, {"Year": 2024, "variable": "Adaptive IMRT for Cervical Cancer Toxicity", "value": -2.1410256410258626}, {"Year": 2013, "variable": "Radiation Therapy Outcomes for Lymphoma Patients", "value": 17.410256410256807}, {"Year": 2014, "variable": "Radiation Therapy Outcomes for Lymphoma Patients", "value": 16.032634032634178}, {"Year": 2015, "variable": "Radiation Therapy Outcomes for Lymphoma Patients", "value": 14.655011655012004}, {"Year": 2016, "variable": "Radiation Therapy Outcomes for Lymphoma Patients", "value": 13.277389277389375}, {"Year": 2017, "variable": "Radiation Therapy Outcomes for Lymphoma Patients", "value": 11.8997668997672}, {"Year": 2018, "variable": "Radiation Therapy Outcomes for Lymphoma Patients", "value": 10.522144522144572}, {"Year": 2019, "variable": "Radiation Therapy Outcomes for Lymphoma Patients", "value": 9.144522144522398}, {"Year": 2020, "variable": "Radiation Therapy Outcomes for Lymphoma Patients", "value": 7.766899766900224}, {"Year": 2021, "variable": "Radiation Therapy Outcomes for Lymphoma Patients", "value": 6.389277389277595}, {"Year": 2022, "variable": "Radiation Therapy Outcomes for Lymphoma Patients", "value": 5.011655011655421}, {"Year": 2023, "variable": "Radiation Therapy Outcomes for Lymphoma Patients", "value": 3.634032634032792}, {"Year": 2024, "variable": "Radiation Therapy Outcomes for Lymphoma Patients", "value": 2.256410256410618}], "data-8c9c571495a43745bc353fbe0c94d115": [{"Year": 2013, "variable": "FLASH Proton RT Normal Tissue Radioprotection", "value": 3}, {"Year": 2014, "variable": "FLASH Proton RT Normal Tissue Radioprotection", "value": 2}, {"Year": 2015, "variable": "FLASH Proton RT Normal Tissue Radioprotection", "value": 1}, {"Year": 2016, "variable": "FLASH Proton RT Normal Tissue Radioprotection", "value": 5}, {"Year": 2017, "variable": "FLASH Proton RT Normal Tissue Radioprotection", "value": 1}, {"Year": 2018, "variable": "FLASH Proton RT Normal Tissue Radioprotection", "value": 1}, {"Year": 2019, "variable": "FLASH Proton RT Normal Tissue Radioprotection", "value": 3}, {"Year": 2020, "variable": "FLASH Proton RT Normal Tissue Radioprotection", "value": 4}, {"Year": 2021, "variable": "FLASH Proton RT Normal Tissue Radioprotection", "value": 8}, {"Year": 2022, "variable": "FLASH Proton RT Normal Tissue Radioprotection", "value": 7}, {"Year": 2023, "variable": "FLASH Proton RT Normal Tissue Radioprotection", "value": 10}, {"Year": 2024, "variable": "FLASH Proton RT Normal Tissue Radioprotection", "value": 5}, {"Year": 2013, "variable": "Proton Therapy for Head and Neck Cancer Survival", "value": 2}, {"Year": 2014, "variable": "Proton Therapy for Head and Neck Cancer Survival", "value": 3}, {"Year": 2015, "variable": "Proton Therapy for Head and Neck Cancer Survival", "value": 6}, {"Year": 2016, "variable": "Proton Therapy for Head and Neck Cancer Survival", "value": 11}, {"Year": 2017, "variable": "Proton Therapy for Head and Neck Cancer Survival", "value": 2}, {"Year": 2018, "variable": "Proton Therapy for Head and Neck Cancer Survival", "value": 8}, {"Year": 2019, "variable": "Proton Therapy for Head and Neck Cancer Survival", "value": 7}, {"Year": 2020, "variable": "Proton Therapy for Head and Neck Cancer Survival", "value": 4}, {"Year": 2021, "variable": "Proton Therapy for Head and Neck Cancer Survival", "value": 12}, {"Year": 2022, "variable": "Proton Therapy for Head and Neck Cancer Survival", "value": 27}, {"Year": 2023, "variable": "Proton Therapy for Head and Neck Cancer Survival", "value": 3}, {"Year": 2024, "variable": "Proton Therapy for Head and Neck Cancer Survival", "value": 2}, {"Year": 2013, "variable": "Radiation Immunotherapy for Tumor Control and Survival", "value": 3}, {"Year": 2014, "variable": "Radiation Immunotherapy for Tumor Control and Survival", "value": 1}, {"Year": 2015, "variable": "Radiation Immunotherapy for Tumor Control and Survival", "value": 2}, {"Year": 2016, "variable": "Radiation Immunotherapy for Tumor Control and Survival", "value": 1}, {"Year": 2017, "variable": "Radiation Immunotherapy for Tumor Control and Survival", "value": 1}, {"Year": 2018, "variable": "Radiation Immunotherapy for Tumor Control and Survival", "value": 4}, {"Year": 2019, "variable": "Radiation Immunotherapy for Tumor Control and Survival", "value": 3}, {"Year": 2020, "variable": "Radiation Immunotherapy for Tumor Control and Survival", "value": 5}, {"Year": 2021, "variable": "Radiation Immunotherapy for Tumor Control and Survival", "value": 10}, {"Year": 2022, "variable": "Radiation Immunotherapy for Tumor Control and Survival", "value": 6}, {"Year": 2023, "variable": "Radiation Immunotherapy for Tumor Control and Survival", "value": 10}, {"Year": 2024, "variable": "Radiation Immunotherapy for Tumor Control and Survival", "value": 1}, {"Year": 2013, "variable": "IMRT for Head Neck Cancer Toxicity and Survival", "value": 37}, {"Year": 2014, "variable": "IMRT for Head Neck Cancer Toxicity and Survival", "value": 28}, {"Year": 2015, "variable": "IMRT for Head Neck Cancer Toxicity and Survival", "value": 30}, {"Year": 2016, "variable": "IMRT for Head Neck Cancer Toxicity and Survival", "value": 37}, {"Year": 2017, "variable": "IMRT for Head Neck Cancer Toxicity and Survival", "value": 37}, {"Year": 2018, "variable": "IMRT for Head Neck Cancer Toxicity and Survival", "value": 34}, {"Year": 2019, "variable": "IMRT for Head Neck Cancer Toxicity and Survival", "value": 25}, {"Year": 2020, "variable": "IMRT for Head Neck Cancer Toxicity and Survival", "value": 31}, {"Year": 2021, "variable": "IMRT for Head Neck Cancer Toxicity and Survival", "value": 36}, {"Year": 2022, "variable": "IMRT for Head Neck Cancer Toxicity and Survival", "value": 21}, {"Year": 2023, "variable": "IMRT for Head Neck Cancer Toxicity and Survival", "value": 36}, {"Year": 2024, "variable": "IMRT for Head Neck Cancer Toxicity and Survival", "value": 8}, {"Year": 2013, "variable": "Adaptive IMRT for Cervical Cancer Toxicity", "value": 22}, {"Year": 2014, "variable": "Adaptive IMRT for Cervical Cancer Toxicity", "value": 9}, {"Year": 2015, "variable": "Adaptive IMRT for Cervical Cancer Toxicity", "value": 7}, {"Year": 2016, "variable": "Adaptive IMRT for Cervical Cancer Toxicity", "value": 7}, {"Year": 2017, "variable": "Adaptive IMRT for Cervical Cancer Toxicity", "value": 4}, {"Year": 2018, "variable": "Adaptive IMRT for Cervical Cancer Toxicity", "value": 6}, {"Year": 2019, "variable": "Adaptive IMRT for Cervical Cancer Toxicity", "value": 0}, {"Year": 2020, "variable": "Adaptive IMRT for Cervical Cancer Toxicity", "value": 3}, {"Year": 2021, "variable": "Adaptive IMRT for Cervical Cancer Toxicity", "value": 1}, {"Year": 2022, "variable": "Adaptive IMRT for Cervical Cancer Toxicity", "value": 0}, {"Year": 2023, "variable": "Adaptive IMRT for Cervical Cancer Toxicity", "value": 1}, {"Year": 2024, "variable": "Adaptive IMRT for Cervical Cancer Toxicity", "value": 2}, {"Year": 2013, "variable": "Radiation Therapy Outcomes for Lymphoma Patients", "value": 13}, {"Year": 2014, "variable": "Radiation Therapy Outcomes for Lymphoma Patients", "value": 15}, {"Year": 2015, "variable": "Radiation Therapy Outcomes for Lymphoma Patients", "value": 27}, {"Year": 2016, "variable": "Radiation Therapy Outcomes for Lymphoma Patients", "value": 11}, {"Year": 2017, "variable": "Radiation Therapy Outcomes for Lymphoma Patients", "value": 9}, {"Year": 2018, "variable": "Radiation Therapy Outcomes for Lymphoma Patients", "value": 11}, {"Year": 2019, "variable": "Radiation Therapy Outcomes for Lymphoma Patients", "value": 8}, {"Year": 2020, "variable": "Radiation Therapy Outcomes for Lymphoma Patients", "value": 4}, {"Year": 2021, "variable": "Radiation Therapy Outcomes for Lymphoma Patients", "value": 7}, {"Year": 2022, "variable": "Radiation Therapy Outcomes for Lymphoma Patients", "value": 5}, {"Year": 2023, "variable": "Radiation Therapy Outcomes for Lymphoma Patients", "value": 6}, {"Year": 2024, "variable": "Radiation Therapy Outcomes for Lymphoma Patients", "value": 2}]}};
      var embedOpt = {"mode": "vega-lite"};

      function showError(el, error){
          el.innerHTML = ('<div style="color:red;">'
                          + '<p>JavaScript Error: ' + error.message + '</p>'
                          + "<p>This usually means there's a typo in your chart specification. "
                          + "See the javascript console for the full traceback.</p>"
                          + '</div>');
          throw error;
      }
      const el = document.getElementById('vis');
      vegaEmbed("#vis", spec, embedOpt)
        .catch(error => showError(el, error));
    })(vegaEmbed);

  </script>
  <button onclick="location.href='index.html'">
        Go to Cluster Chart
  </button>
</body>
</html>